,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,regulation of blood vessel endothelial cell migration (GO:0043535),0.8742689072030646,1.7921954003508858,0.0,0.06421990618736458,0.045,3/15,2.58%,APOE;TMSB4X;TNF
55,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7468135710031523,1.6016209783893367,0.0,0.06840125722209134,0.818,47/70,19.30%,RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;PABPC1;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
57,protein targeting to ER (GO:0045047),0.7454432486169568,1.5992482327244146,0.0,0.068325210535151,0.829,47/70,19.30%,RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;ZFAND2A;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
58,translation (GO:0006412),0.7428688904271051,1.598074765776363,0.0,0.06830586632027644,0.834,50/79,19.30%,EEF1A1;RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;LARS2;RPS19;EEF2;EEF1B2;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
60,cytoplasmic translation (GO:0002181),0.7436832788611907,1.5961931004652887,0.0,0.0675564259035303,0.838,46/68,19.30%,RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;EIF4A1;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
62,nuclear-transcribed mRNA catabolic process (GO:0000956),0.7403272444136155,1.5945532068536643,0.0,0.06663501377047915,0.844,51/80,19.30%,RPLP1;RPS5;ZFP36;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;PATL2;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;ZFP36L1;RPL19;RPS18;RPL18A;RPL26;DDX5;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;PABPC1;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
66,cotranslational protein targeting to membrane (GO:0006613),0.7420191022030033,1.5831276243456551,0.0,0.07168150722773346,0.88,46/69,19.30%,RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
75,cellular protein metabolic process (GO:0044267),0.7271086408923623,1.574887664159975,0.0,0.07008289762268874,0.904,60/122,18.37%,APOE;SPP1;EEF1A1;CSF1;RPLP1;CST3;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;IGF1;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;APLP2;RPS21;MAN2B1;RPL41;RPS20;CTSH;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;SHISA5;RPS25;RPS11;RPL18;RPS26;RPS10;LGMN;RPL22;RPL37A;SERP1;CSF2RA;RPS8;UBE2D3;RPL6;RPL3;CSF2RB;RPS15A;RPS2;RPL21;RPL37;RPN2;RPS17;RPL29;RPL11
76,regulation of inflammatory response (GO:0050727),0.7390763216682849,1.5742390201266556,0.0,0.06967314497450343,0.907,13/48,7.50%,APOE;CCL3;IL1B;TMSB4X;LPL;TNF;NFKBIA;GRN;TLR2;SIRPA;NFKBIZ;OSM;TNFAIP3
199,regulation of gene expression (GO:0010468),0.613048364499251,1.3424043230169962,0.0,0.24070921621043656,1.0,31/164,11.16%,APOE;CCL3;TYROBP;TREM2;CSF1;IL1B;CLEC7A;ID2;TNF;RPS3;RACK1;TLR2;IGF1;NFE2L2;SIRPA;BTG1;NFKBIZ;CEBPB;RPL23;ITGAX;CD74;CTSH;ZFP36L1;GPX1;PTPRC;DDX3X;EGR1;SLC11A1;PFDN5;TAPBP;LGMN
53,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.7502201833928529,1.6027835035354019,0.0,0.06989174975377,0.812,46/66,19.30%,RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
88,positive regulation of macromolecule metabolic process (GO:0010604),0.7163117237757537,1.5515337217769625,0.0,0.07850703138410411,0.951,20/77,8.48%,CCL3;TYROBP;TREM2;CSF1;IL1B;CLEC7A;CD63;ID2;TNF;RPS3;TLR2;IGF1;NFE2L2;LAPTM5;RPL23;ITGAX;CD74;CTSH;DDX3X;EGR1
92,positive regulation of MAPK cascade (GO:0043410),0.7221856401477155,1.544505185017423,0.0,0.08087777432661812,0.966,12/45,9.84%,APOE;CCL3;CCL4;TREM2;TNF;IGF1;LAPTM5;CD74;OSM;PTPRC;C5AR1;NRP1
101,ncRNA processing (GO:0034470),0.72595348395954,1.5363886217420637,0.0,0.080647803758069,0.972,36/55,20.91%,RPLP1;RPS14;RPLP0;RPS9;RPS15;RPL32;RPL8;RPL4;RPS24;RPL23;RPLP2;RPL41;RPS19;RPL19;RPL18A;RPL26;RPL34;RPL14;RPL7;RPS25;RPL18;RPL22;RPL37A;RPL6;RPL3;HNRNPA2B1;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28;RPL35A;RPL10A
102,ribosome biogenesis (GO:0042254),0.7239475175291388,1.5353899641582476,0.0,0.08076648395782071,0.973,36/56,20.91%,RPLP1;RPS14;RPLP0;RPS9;RPS15;RPL32;RPL8;RPL4;RPS24;RPL23;RPLP2;RPL41;RPS19;RPL19;RPL18A;RPL26;RPL34;RPL14;RPL7;RPS25;RPL18;RPL22;RPL37A;RPL6;RPL3;RPS2;NPM1;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28;RPL35A;RPL10A
104,rRNA processing (GO:0006364),0.7226162180311968,1.5311965794331244,0.0,0.08282250758405613,0.977,35/55,20.91%,RPLP1;RPS14;RPLP0;RPS9;RPS15;RPL32;RPL8;RPL4;RPS24;RPL23;RPLP2;RPL41;RPS19;RPL19;RPL18A;RPL26;RPL34;RPL14;RPL7;RPS25;RPL18;RPL22;RPL37A;RPL6;RPL3;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28;RPL35A;RPL10A
133,neutrophil activation involved in immune response (GO:0002283),0.6743352933212107,1.478677330950513,0.0,0.11064846523005513,0.999,51/175,11.94%,FTH1;CTSB;EEF1A1;TYROBP;CD14;CTSZ;CTSS;CD68;CST3;NPC2;CD63;FCER1G;B2M;TIMP2;ATP6V0C;GRN;TLR2;CTSA;SIRPA;SYNGR1;PSAP;CYBB;ALDOA;MAN2B1;ITGAX;PKM;GUSB;CTSH;LGALS3;EEF2;LAMP2;ANXA3;CREG1;C3AR1;SDCBP;GNS;HEXB;PTPRC;DDX3X;PLAUR;GM2A;C5AR1;ITGB2;RAP1B;SLC11A1;ARPC5;BRI3;CTSC;HSP90AB1;FABP5;CD53
132,neutrophil mediated immunity (GO:0002446),0.6735786425928247,1.478800947750807,0.0,0.11133926592668829,0.999,51/176,11.94%,FTH1;CTSB;EEF1A1;TYROBP;CD14;CTSZ;CTSS;CD68;CST3;NPC2;CD63;FCER1G;B2M;TIMP2;ATP6V0C;GRN;TLR2;CTSA;SIRPA;SYNGR1;PSAP;CYBB;ALDOA;MAN2B1;ITGAX;PKM;GUSB;CTSH;LGALS3;EEF2;LAMP2;ANXA3;CREG1;C3AR1;SDCBP;GNS;HEXB;PTPRC;DDX3X;PLAUR;GM2A;C5AR1;ITGB2;RAP1B;SLC11A1;ARPC5;BRI3;CTSC;HSP90AB1;FABP5;CD53
130,neutrophil degranulation (GO:0043312),0.6753437658681567,1.4811114547938187,0.0,0.1103315334838469,0.999,51/174,11.94%,FTH1;CTSB;EEF1A1;TYROBP;CD14;CTSZ;CTSS;CD68;CST3;NPC2;CD63;FCER1G;B2M;TIMP2;ATP6V0C;GRN;TLR2;CTSA;SIRPA;SYNGR1;PSAP;CYBB;ALDOA;MAN2B1;ITGAX;PKM;GUSB;CTSH;LGALS3;EEF2;LAMP2;ANXA3;CREG1;C3AR1;SDCBP;GNS;HEXB;PTPRC;DDX3X;PLAUR;GM2A;C5AR1;ITGB2;RAP1B;SLC11A1;ARPC5;BRI3;CTSC;HSP90AB1;FABP5;CD53
109,gene expression (GO:0010467),0.7012214369572107,1.5204474585202887,0.0,0.0878510353033025,0.986,54/99,20.91%,EEF1A1;RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;PTMA;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;APOBEC1;RPL3;HNRNPA2B1;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28;RBMS1;HNRNPK;RPL35A;RPL10A
110,rRNA metabolic process (GO:0016072),0.7187257799657201,1.5201630904505041,0.0,0.0873622147233518,0.988,35/55,20.91%,RPLP1;RPS14;RPLP0;RPS9;RPS15;RPL32;RPL8;RPL4;RPS24;RPL23;RPLP2;RPL41;RPS19;RPL19;RPL18A;RPL26;RPL34;RPL14;RPL7;RPS25;RPL18;RPL22;RPL37A;RPL6;RPL3;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28;RPL35A;RPL10A
144,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2381188118811881,-1.4461815995189415,0.0,0.6609127762521251,0.26834170854271355,32/32,76.61%,GPR132;ACTR1A;PSMC3;VPS4B;PSMD14;PSMA1;MAPRE1;ODF2;PSMD4;PSMA2;RBX1;PAFAH1B1;PSMB2;PPP2R1A;CSNK1D;PSMB3;PSMB8;DCTN2;DYNC1H1;YWHAG;DYNLL1;BRD4;TUBA4A;PSMB9;YWHAE;PSMD8;PSMA7;PSMA6;PSMB4;PSMB1;PSME1;PSMB6
45,peptide biosynthetic process (GO:0043043),0.7535769818949821,1.6154609780394962,0.0,0.06913842074151391,0.758,47/69,19.30%,EEF1A1;RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;RPL19;RPS18;RPL18A;RPL26;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A;RPS8;RPL6;RPL3;RPS15A;RPS2;RPL21;RPL37;RPS17;RPL29;RPL11;RPL39;RPS28
59,cellular macromolecule biosynthetic process (GO:0034645),0.7427629118699995,1.5976115230168495,0.0,0.06752970135240567,0.835,39/87,11.79%,APOE;EEF1A1;RPLP1;RPS5;RPS14;RPLP0;RPS9;RPS3;RPS15;RPL32;RPL8;RPL4;RPSA;RPS24;RPL23;RPS4X;RPLP2;RPS21;RPL41;RPS20;RPS19;EEF2;EEF1B2;RPL19;RPS18;RPL18A;RPL26;PTMA;RPL34;RPL14;RPS29;RPL7;RPS25;RPS11;RPL18;RPS26;RPS10;RPL22;RPL37A
17,positive regulation of protein metabolic process (GO:0051247),0.8022216724287932,1.6726790031673322,0.0,0.07552700078103732,0.51,5/31,2.78%,APOE;CSF1;IL1B;TNF;NFKBIA
8,cytoskeleton organization (GO:0007010),0.8274809893273943,1.6940030798252617,0.0,0.10000740946442585,0.405,2/20,0.34%,APOE;CCL3
1,regulation of protein secretion (GO:0050708),0.8586272168473172,1.7844941525935518,0.0,0.03951994226914743,0.058,5/24,3.12%,APOE;TREM2;IL1B;TNF;IGF1
128,positive regulation of gene expression (GO:0010628),0.6828477679981176,1.4876850891195552,0.001,0.10491166069821346,0.998,24/101,8.48%,CCL3;TYROBP;TREM2;CSF1;ACTB;IL1B;CLEC7A;ID2;TNF;RPS3;TLR2;IGF1;NFE2L2;RPL23;RPS4X;ITGAX;CD74;CTSH;EEF2;RPL26;CADM1;DDX5;DDX3X;EGR1
160,positive regulation of cytokine production (GO:0001819),0.6523370545852482,1.415227322034831,0.001,0.16571823291829837,1.0,27/80,15.50%,TYROBP;CD14;IL1B;CLEC7A;LPL;FCER1G;TNF;RPS3;TLR2;LAPTM5;CEBPB;CD74;OSM;CADM1;PTPRC;EGR1;CRLF2;RAB7B;SLC11A1;IRF1;SERPINE1;CSF1R;TLR7;CD274;PDE4B;STAT3;CD86
97,regulated exocytosis (GO:0045055),0.7210055216340737,1.5392792748599384,0.001002004008016032,0.08139898313293274,0.97,17/44,12.72%,SRGN;CD9;TMSB4X;CD63;LGALS3BP;PLEK;IGF1;SYNGR1;APLP2;PSAP;ALDOA;CALM1;LAMP2;ANXA5;SDF4;SERPINE1;TAGLN2
26,positive regulation of cellular component organization (GO:0051130),0.7863202754429842,1.6485486497109798,0.001002004008016032,0.07402670667637523,0.627,8/32,7.21%,APOE;TREM2;CLEC7A;TNF;RPS3;RACK1;LGALS3;GPX1
50,regulation of interleukin-6 production (GO:0032675),0.757130783362034,1.6086354027705088,0.001002004008016032,0.06853997830796256,0.784,16/33,14.86%,TYROBP;TREM2;IL1B;CLEC7A;LPL;TNF;TLR2;SIRPA;CD74;TNFAIP3;RAB7B;MAPKAPK2;TLR7;CD47;PTPN6;STAT3
41,platelet degranulation (GO:0002576),0.7651391496303549,1.621403162091974,0.001002004008016032,0.07019494507805711,0.743,13/33,6.68%,SRGN;CD9;TMSB4X;CD63;LGALS3BP;PLEK;IGF1;APLP2;PSAP;ALDOA;CALM1;LAMP2;ANXA5
46,regulation of tumor necrosis factor production (GO:0032680),0.749853603889837,1.6153940471616772,0.0010050251256281408,0.06770943300474673,0.758,11/36,7.55%,CCL3;TYROBP;CD14;CLEC7A;LPL;ZFP36;TLR2;IGF1;SIRPA;TNFAIP3;PTPRC
12,negative regulation of cellular protein metabolic process (GO:0032269),0.8220350761271625,1.681868151376892,0.0010162601626016261,0.08876787032762345,0.465,7/22,4.48%,APOE;CST3;RPS3;RACK1;BTG2;PATL2;SERPINE2
5,negative regulation of cellular amide metabolic process (GO:0034249),0.8293901691330202,1.7070865130084256,0.0010183299389002036,0.1151018318588919,0.34,6/20,3.51%,APOE;RPS3;RACK1;IGF1;BTG2;PATL2
20,positive regulation of developmental process (GO:0051094),0.7984479476299955,1.6591377124460385,0.0010204081632653062,0.08101588165175225,0.582,3/20,4.24%,APOE;TNF;CEBPB
2,regulation of cellular protein metabolic process (GO:0032268),0.8799806290321295,1.7714525409723556,0.0010384215991692627,0.04017860797363322,0.081,3/15,2.78%,APOE;CSF1;NFKBIA
4,positive regulation of neuron death (GO:1901216),0.8581919411620745,1.7358558692253936,0.001040582726326743,0.07469269088868864,0.22,9/15,8.97%,CCL3;TYROBP;TNF;GRN;C1QA;FOS;FCGR2B;EGR1;ITGB2
31,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.7704095357528635,1.637171380230056,0.0020161290322580645,0.07400726688995812,0.677,6/27,3.02%,CCL3;TYROBP;CD14;CLEC7A;LPL;TLR2
29,positive regulation of protein catabolic process (GO:0045732),0.7872879645131188,1.6411066279230753,0.002026342451874367,0.07423162489554859,0.662,3/25,2.58%,APOE;IL1B;TNF
9,positive regulation of tumor necrosis factor production (GO:0032760),0.7932832675471866,1.6903405581131392,0.002026342451874367,0.096231059425374,0.421,6/24,3.02%,CCL3;TYROBP;CD14;CLEC7A;LPL;TLR2
37,regulation of protein metabolic process (GO:0051246),0.79596171042772,1.6344012618807404,0.0020554984583761563,0.06486990523784397,0.693,1/18,0.05%,APOE
7,positive regulation of proteolysis (GO:0045862),0.8264358072481368,1.6984265149446955,0.0020768431983385254,0.10250485026060116,0.375,4/17,5.70%,APOE;IL1B;TNF;CTSH
13,cellular response to hormone stimulus (GO:0032870),0.8160410405361851,1.679048007935268,0.0020833333333333333,0.08708501564308557,0.478,5/15,6.19%,CTSB;CTSL;CTSS;CTSH;ZFP36L1
191,cellular response to cytokine stimulus (GO:0071345),0.6208959356253336,1.3566679944705975,0.003,0.22399117017521233,1.0,42/120,19.01%,CCL3;CCL4;CSF1;IL1B;ZFP36;TNF;RPS3;TLR2;JUNB;NFE2L2;SIRPA;DUSP1;AXL;CDKN1A;MCL1;ITGAX;FOS;OSM;ZFP36L1;CXCL2;EGR1;SOCS3;PIM1;ITGB2;CRLF2;UBC;UBB;IRF1;CSF2RA;CSF1R;VIM;CD47;PTPN6;STAT3;CSF2RB;CD86;GRB2;YWHAZ;CSF3R;PTGS2;NFKB1;SBNO2
177,positive regulation of cellular process (GO:0048522),0.6348532001776289,1.3761035291577466,0.003,0.20818301791950886,1.0,45/126,17.06%,CST7;TREM2;CSF1;IL1B;CLEC7A;FCER1G;ZFP36;TNF;RPS9;GRN;TLR2;IGF1;SIRPA;RPL23;RPS4X;ITGAX;CTSH;RPS19;OSM;ZFP36L1;SDCBP;CD81;FCGR2B;DDX3X;CRLF2;CXCL16;SLC11A1;GNAI2;TGFBR2;LGMN;HSP90AB1;IER5;CSF1R;S100A9;CD47;CDC42;PTPN6;LRP1;CD86;SLC25A5;RPS15A;NPM1;FGFR2;S100A8;CALR
145,negative regulation of gene expression (GO:0010629),0.6685052191404284,1.444095470793654,0.003,0.14160404142024516,1.0,11/72,3.51%,APOE;CCL3;SRGN;ID2;ZFP36;TNF;RPS3;RACK1;IGF1;BTG2;PATL2
22,proteolysis involved in cellular protein catabolic process (GO:0051603),0.8001132487755992,1.65355335559995,0.0030303030303030303,0.08080109935681122,0.607,10/24,11.16%,CTSB;CTSL;CTSZ;CTSS;CTSH;TNFAIP3;UBC;UBB;CTSC;LGMN
10,regulation of MAP kinase activity (GO:0043405),0.808970744979334,1.6843566318184644,0.00303951367781155,0.09862021957164518,0.447,4/22,3.75%,APOE;IL1B;TNF;DUSP1
23,positive regulation of binding (GO:0051099),0.8044027257170706,1.653218532760963,0.003045685279187817,0.07784605294891436,0.607,3/20,3.12%,APOE;B2M;IGF1
27,cellular protein catabolic process (GO:0044257),0.8074134228401183,1.6476759687984412,0.0030581039755351682,0.0722650372921553,0.633,8/18,11.16%,CTSB;CTSL;CTSZ;CTSS;CTSH;CLTA;CTSC;LGMN
14,regulation of interleukin-1 beta production (GO:0032651),0.8043857065739293,1.6789836484512048,0.0030581039755351682,0.08127934793354655,0.478,9/22,8.48%,CCL3;TYROBP;CLEC7A;LPL;TNF;IGF1;SIRPA;TNFAIP3;EGR1
11,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.8216286734454604,1.682310075477671,0.0030737704918032786,0.09484786144595383,0.461,3/18,3.75%,APOE;IL1B;DUSP1
3,regulation of neuron apoptotic process (GO:0043523),0.8507428453863991,1.7644296561676491,0.003083247687564234,0.040013941547511776,0.107,5/19,2.97%,APOE;CCL3;TREM2;TNF;GRN
54,positive regulation of cellular catabolic process (GO:0031331),0.758524241458118,1.6019145091691653,0.004,0.06939342590259842,0.817,5/32,3.80%,APOE;IL1B;TNF;IGF1;LAPTM5
111,regulation of ERK1 and ERK2 cascade (GO:0070372),0.7221798411499898,1.5192178698835592,0.004004004004004004,0.08740258660774837,0.989,18/43,16.96%,APOE;CCL3;CCL4;TREM2;IL1B;TNF;SIRPA;CD74;PTPRC;C5AR1;NRP1;GPNMB;CSF1R;ATP6AP1;PTPN6;PTPN1;FGFR2;YWHAZ
74,positive regulation of response to external stimulus (GO:0032103),0.7415839081291133,1.5758587500640742,0.004012036108324975,0.07020059078409556,0.898,11/32,6.04%,CCL3;TREM2;IL1B;LPL;TNF;NFKBIA;GRN;TLR2;NFKBIZ;LY86;OSM
43,positive regulation of inflammatory response (GO:0050729),0.7630818469314222,1.6186191273302315,0.004012036108324975,0.0694293531228431,0.748,17/27,17.01%,CCL3;IL1B;LPL;TNF;NFKBIA;GRN;TLR2;NFKBIZ;RPS19;OSM;CD81;SERPINE1;TLR7;S100A9;CD47;S100A8;PTGER4
56,positive regulation of interleukin-6 production (GO:0032755),0.7563820985339087,1.599709689328432,0.004032258064516129,0.06907323243094408,0.826,7/24,5.26%,TYROBP;IL1B;CLEC7A;LPL;TNF;TLR2;CD74
33,negative regulation of MAPK cascade (GO:0043409),0.790781943491923,1.6366131680382239,0.004036326942482341,0.07038036777637872,0.681,4/23,3.75%,APOE;IL1B;SIRPA;DUSP1
28,positive regulation of cellular metabolic process (GO:0031325),0.7835749380784145,1.6444150167130218,0.004048582995951417,0.07307782428217348,0.644,5/27,4.39%,APOE;CSF1;CD63;NFKBIA;CDKN1A
21,pattern recognition receptor signaling pathway (GO:0002221),0.7914796490284229,1.654062279256642,0.004077471967380225,0.08389005927132659,0.604,11/22,13.60%,CTSB;CTSL;CD14;CTSS;TLR2;UBC;UBB;LGMN;MAPKAPK2;TLR7;S100A9
161,positive regulation of nucleic acid-templated transcription (GO:1903508),0.6559450329762558,1.4148427611161065,0.005,0.16527804427561302,1.0,9/74,5.65%,APOE;SPP1;IL1B;ID2;TNF;IGF1;CEBPB;CD74;FOS
119,inflammatory response (GO:0006954),0.7026909991031661,1.5043884473326854,0.005,0.09545712722260319,0.995,26/52,19.88%,CCL3;CCL4;CD14;IL1B;TNF;TLR2;CEBPB;CYBB;FOS;CCRL2;C3AR1;FCGR2B;CXCL2;C5AR1;ITGB2;SLC11A1;MAPKAPK2;CSF1R;S100A9;PRDX5;STAT3;S100A8;PTGER4;NFKB1;CD44;NLRP3
192,regulation of cell population proliferation (GO:0042127),0.6214328840708417,1.3562176769199894,0.005,0.22355011093731406,1.0,38/122,16.28%,FTH1;CSF1;IL1B;CLEC7A;ID2;RPS9;IGF1;JUNB;BTG2;BTG1;RPL23;CDKN1A;RPS4X;ITGAX;CTSH;OSM;ZFP36L1;SDCBP;CD81;ADAMTS1;CRLF2;GNAI2;IRF1;TGFBR2;LGMN;GPNMB;IER5;CSF1R;CD47;PTPN6;STAT3;SGK1;TSPO;CD86;SLC25A5;RPS15A;NPM1;FGFR2
118,negative regulation of macromolecule metabolic process (GO:0010605),0.6964674234830364,1.5056764038814445,0.005,0.09514675176563647,0.994,6/47,3.12%,APOE;CCL3;ID2;TNF;RACK1;IGF1
70,positive regulation of hydrolase activity (GO:0051345),0.7517034316613046,1.5779395632515392,0.005040322580645161,0.07216564105908402,0.896,7/26,5.70%,CCL3;CCL4;RPS3;RACK1;PSAP;CALM1;CTSH
16,positive regulation of transport (GO:0051050),0.8071380495322324,1.6729483213346659,0.005045408678102927,0.07956294259773945,0.508,8/25,3.56%,APOE;TREM2;ACTB;IL1B;CLEC7A;FCER1G;TNF;SIRPA
25,regulation of endothelial cell proliferation (GO:0001936),0.7970810059538292,1.649103050146143,0.00511770726714432,0.0761898887015775,0.623,1/18,0.05%,APOE
96,proteolysis (GO:0006508),0.7246016895220286,1.5409980015120417,0.006006006006006006,0.08067975843142186,0.97,13/38,15.64%,CTSB;CTSL;CTSZ;CTSS;SRGN;CTSA;CTSH;CTSC;LGMN;CNDP2;CTSE;TPP1;CPD
98,organonitrogen compound biosynthetic process (GO:1901566),0.7258056870052267,1.5390873879877,0.006024096385542169,0.08068654879950933,0.971,1/27,0.05%,APOE
51,regulation of NIK/NF-kappaB signaling (GO:1901222),0.7708334425773478,1.6072452812287192,0.006048387096774193,0.06858989980366452,0.794,8/24,3.80%,CD14;IL1B;TMSB4X;TNF;RPS3;NFKBIA;TLR2;LAPTM5
39,positive regulation of supramolecular fiber organization (GO:1902905),0.8010074011761114,1.6273462496094497,0.006153846153846154,0.06797430070293359,0.719,3/19,2.83%,APOE;RPS3;PLEK
6,plasma membrane bounded cell projection organization (GO:0120036),0.8339693510698467,1.699956560988821,0.006166495375128468,0.11460783258052755,0.369,3/17,3.46%,APOE;PLEK;BTG2
24,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.8062994362775568,1.6514681308111898,0.006198347107438017,0.07627348857945455,0.612,7/15,8.04%,CD14;IL1B;TNF;RPS3;TLR2;LAPTM5;DDX3X
72,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.7533445285001034,1.576966706387841,0.007021063189568706,0.07104115649683385,0.898,12/30,14.08%,APOE;CCL3;CCL4;TREM2;TNF;CD74;PTPRC;C5AR1;NRP1;GPNMB;CSF1R;ATP6AP1
112,receptor-mediated endocytosis (GO:0006898),0.7096138757464663,1.5186999987994854,0.007021063189568706,0.08704004984277935,0.989,16/43,17.06%,APOE;CTSL;CD9;FCER1G;CLTA;CD81;FCGR2B;ITGB2;CXCL16;PPT1;CANX;LRP1;RAMP1;GRB2;DAB2;CALR
71,toll-like receptor signaling pathway (GO:0002224),0.74899112120933,1.5777724746488306,0.007028112449799197,0.07128684030841004,0.897,13/31,13.79%,CTSB;CTSL;CD14;CTSS;TLR2;ITGB2;UBC;UBB;LGMN;MAPKAPK2;TLR7;S100A9;UBE2D3
63,regulation of interleukin-8 production (GO:0032677),0.7643827241995023,1.5930566119086698,0.007035175879396985,0.06655096528214632,0.851,11/24,14.86%,CD14;IL1B;CLEC7A;TMSB4X;TNF;TLR2;CD74;PTPRC;SERPINE1;TLR7;STAT3
47,regulation of defense response (GO:0031347),0.7868923010515967,1.6143558079157834,0.007070707070707071,0.06759556792285425,0.76,4/22,2.97%,APOE;TREM2;TMSB4X;GRN
52,regulation of cellular component organization (GO:0051128),0.7759456536600525,1.604727322747601,0.00708502024291498,0.06958865306166385,0.806,2/21,2.58%,APOE;TNF
38,positive regulation of chemokine production (GO:0032722),0.7925232759728915,1.6313289256863703,0.007150153217568948,0.06579057055959993,0.699,10/18,13.21%,IL1B;CLEC7A;LPL;TNF;TLR2;CD74;DDX3X;EGR1;CSF1R;TLR7
48,chemical synaptic transmission (GO:0007268),0.7954509190291303,1.611973663577566,0.0071794871794871795,0.06853483865960822,0.772,5/17,9.99%,APOE;CALM1;GABARAP;SDCBP;PMP22
32,negative regulation of neuron apoptotic process (GO:0043524),0.8013756086217143,1.6366997934326653,0.007268951194184839,0.07239334879302917,0.681,2/15,2.97%,APOE;GRN
40,positive regulation of neuron projection development (GO:0010976),0.8064668091100182,1.6241975533544841,0.007276507276507277,0.06918399649678188,0.731,1/15,0.05%,APOE
15,positive regulation of interleukin-1 production (GO:0032732),0.8185468436896429,1.6733946688801402,0.007291666666666667,0.08410337714152938,0.507,5/16,2.58%,CCL3;TYROBP;CLEC7A;LPL;TNF
18,positive regulation of interleukin-1 beta production (GO:0032731),0.825449778822895,1.671897626466312,0.007322175732217573,0.0722798944133091,0.512,5/15,2.58%,CCL3;TYROBP;CLEC7A;LPL;TNF
125,positive regulation of multicellular organismal process (GO:0051240),0.6954927226272553,1.4963037415337805,0.008,0.09850188785417263,0.998,16/50,12.33%,APOE;TREM2;IL1B;TNF;CEBPB;ITGAX;RPS19;CADM1;SDCBP;LRPAP1;HCAR2;SLC11A1;TGFBR2;SERPINE1;FABP5;ABCA1
95,positive regulation of cellular component biogenesis (GO:0044089),0.7377299061259854,1.5414990818002168,0.00808080808080808,0.08101588165175223,0.97,8/27,7.26%,CLEC7A;TNF;RPS3;PLEK;RACK1;SDC4;LGALS3;SDCBP
30,positive regulation of endocytosis (GO:0045807),0.8052770283481983,1.6407958433116523,0.00819672131147541,0.07202828187763967,0.663,4/16,4.00%,APOE;TREM2;B2M;AXL
61,positive regulation of interleukin-8 production (GO:0032757),0.7817288870346246,1.595682109319242,0.008238928939237899,0.06688112810629507,0.84,9/18,14.86%,CD14;IL1B;CLEC7A;TNF;TLR2;CD74;SERPINE1;TLR7;STAT3
107,positive regulation of signal transduction (GO:0009967),0.7168981886947448,1.5226627383107976,0.009018036072144289,0.08771231631402444,0.984,14/40,9.84%,TREM2;IL1B;CD63;ATP6V0C;RPS3;TLR2;IGF1;LY86;AXL;CD74;TNFAIP3;PTPRC;CRLF2;NRP1
79,negative regulation of neuron death (GO:1901215),0.7469016799592887,1.5674392157004218,0.009054325955734407,0.0726055439375993,0.913,3/25,2.97%,APOE;CSF1;GRN
69,positive regulation of defense response (GO:0031349),0.7443269828101496,1.5781016597913107,0.00906344410876133,0.07311189319792274,0.896,15/26,17.01%,CCL3;IL1B;LPL;TNF;NFKBIA;GRN;TLR2;NFKBIZ;OSM;SERPINE1;TLR7;S100A9;CD47;S100A8;PTGER4
35,neuron development (GO:0048666),0.7955666080398838,1.6356840196267934,0.009259259259259259,0.0673211238793185,0.686,2/19,3.46%,APOE;BTG2
64,regulation of endothelial cell migration (GO:0010594),0.767271586460311,1.5929373457260745,0.01020408163265306,0.06561830414458056,0.851,4/19,9.84%,APOE;GRN;ANXA3;NRP1
36,response to interferon-gamma (GO:0034341),0.7880176929934921,1.635295609723784,0.010330578512396695,0.0657953633453914,0.687,8/18,9.89%,CCL3;CCL4;TLR2;SIRPA;CD74;IFITM3;CXCL16;SLC11A1
19,regulation of interferon-gamma production (GO:0032649),0.8125716911839473,1.6711058602507356,0.010395010395010396,0.06960449832153591,0.516,11/16,14.23%,CD14;IL1B;CLEC7A;SIRPA;LAPTM5;AXL;SLC11A1;TLR7;CD274;PDE4B;CD47
189,negative regulation of cellular process (GO:0048523),0.632387062403201,1.3588971705072521,0.011,0.22257150555469443,1.0,21/85,11.99%,FTH1;TREM2;CD9;IL1B;RACK1;TLR2;BTG2;SIRPA;BTG1;DUSP1;CDKN1A;OSM;NR4A1;FCGR2B;DDX3X;ADAMTS1;LRPAP1;IRF1;PPT1;ARHGDIA;GPNMB
122,regulation of macromolecule metabolic process (GO:0060255),0.7141942560910755,1.501396791306101,0.011055276381909548,0.09590815258000414,0.996,7/35,7.55%,APOE;TREM2;IGF1;SIRPA;NFKBIZ;ZFP36L1;PTPRC
121,cellular response to molecule of bacterial origin (GO:0071219),0.706257916334686,1.5020127766021483,0.011077542799597181,0.09611120386275444,0.996,18/33,19.88%,CD14;CD68;IL1B;ZFP36;TLR2;SIRPA;AXL;TNFAIP3;FCGR2B;CXCL2;SERPINE1;CD274;PDE4B;VIM;CD86;NFKB1;SBNO2;NLRP3
142,negative regulation of cell population proliferation (GO:0008285),0.6830746283441055,1.454637480381921,0.012,0.13043653673063538,1.0,12/46,11.99%,FTH1;TREM2;IL1B;B2M;BTG2;BTG1;CDKN1A;OSM;TNFAIP3;ADAMTS1;IRF1;GPNMB
135,negative regulation of cytokine production (GO:0001818),0.6948422851504674,1.4732796914128026,0.012012012012012012,0.11470953831430844,1.0,18/45,15.45%,TYROBP;TREM2;SRGN;TMSB4X;ZFP36;TNF;SIRPA;LAPTM5;AXL;TNFAIP3;PTPRC;FCGR2B;SLC11A1;CD84;GPNMB;CD274;PTPN6;NPTN
129,cellular response to lipopolysaccharide (GO:0071222),0.7014641908696614,1.4871619668086244,0.012024048096192385,0.10461384717977198,0.998,14/37,13.65%,CCL3;CD14;CD68;IL1B;ZFP36;TNF;SIRPA;AXL;TNFAIP3;CXCL2;SERPINE1;CD274;PDE4B;VIM
90,regulation of protein-containing complex assembly (GO:0043254),0.7389664118419138,1.5489834695457407,0.012060301507537688,0.0786598850933992,0.957,7/32,8.04%,APOE;CLEC7A;TNF;RPS3;RACK1;LGALS3;DDX3X
137,cellular response to lipid (GO:0071396),0.6881628317739863,1.4688157599188179,0.012060301507537688,0.11785104523413693,1.0,15/43,13.65%,SPP1;CD14;CD68;IL1B;LPL;ZFP36;SIRPA;AXL;TNFAIP3;CXCL2;SERPINE1;MSN;CD274;PDE4B;VIM
78,regulation of phagocytosis (GO:0050764),0.7629858038904104,1.5713778314125226,0.0121580547112462,0.07023544170364936,0.911,11/24,9.89%,TREM2;IL1B;CLEC7A;FCER1G;TNF;RACK1;TLR2;SIRPA;PTPRC;FCGR2B;SLC11A1
65,neuron projection development (GO:0031175),0.770981175294028,1.5835787446866556,0.012269938650306749,0.07230353074241747,0.879,2/20,3.46%,APOE;BTG2
34,regulation of epithelial cell proliferation (GO:0050678),0.7877390261723148,1.6359126982445278,0.012320328542094456,0.06890584219927777,0.683,8/18,8.87%,B2M;ZFP36;GRN;IGF1;ZFP36L1;GPX1;NR4A1;C5AR1
42,response to reactive oxygen species (GO:0000302),0.8007827169474181,1.621398639234363,0.012396694214876033,0.06856250449484647,0.743,4/17,7.21%,APOE;RPS3;FOS;GPX1
184,cellular response to oxygen-containing compound (GO:1901701),0.6364617144091473,1.3648650314922288,0.013,0.21866985447945111,1.0,21/69,13.94%,CD14;CD68;ACTB;IL1B;LPL;ZFP36;RPS3;TLR2;SIRPA;AXL;FOS;ZFP36L1;TNFAIP3;CXCL2;EGR1;RAP1B;SERPINE1;CD274;PDE4B;VIM;PRDX5
77,negative regulation of inflammatory response (GO:0050728),0.7471982427217717,1.5716202574869742,0.013052208835341365,0.07095856301018073,0.91,7/31,7.50%,APOE;TREM2;GRN;IGF1;SIRPA;RPS19;TNFAIP3
99,regulation of primary metabolic process (GO:0080090),0.7272310033071951,1.5365608087400673,0.013078470824949699,0.08208292009301922,0.972,3/30,4.92%,APOE;ID2;PSAP
94,regulation of neuron death (GO:1901214),0.7439312264402438,1.542200950355335,0.01314459049544995,0.08124468131752098,0.969,10/26,11.99%,TYROBP;CTSZ;CSF1;C1QA;FOS;FCGR2B;EGR1;ITGB2;UBB;GPNMB
81,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.7503622487693589,1.5609949627212611,0.013197969543147208,0.07606384010522187,0.926,1/23,0.05%,APOE
151,cellular response to tumor necrosis factor (GO:0071356),0.6614532721640886,1.4254207480384227,0.014,0.16050723572921452,1.0,10/53,8.33%,CCL3;CCL4;TMSB4X;ZFP36;TNF;RPS3;NFKBIA;NFE2L2;ZFP36L1;TNFSF9
206,positive regulation of cell population proliferation (GO:0008284),0.6137742886600038,1.3327713696576842,0.014,0.24941687836950763,1.0,33/95,17.06%,CSF1;IL1B;CLEC7A;ID2;TNF;RPS9;GRN;IGF1;RPL23;CDKN1A;RPS4X;ITGAX;CD74;CTSH;OSM;SDCBP;CD81;PTPRC;C5AR1;PIM1;CRLF2;GNAI2;TGFBR2;LGMN;CSF1R;CD47;PTPN6;CD86;SLC25A5;RPS15A;NPM1;FGFR2;CALR
147,post-translational protein modification (GO:0043687),0.6730071340940501,1.432949054911568,0.014,0.15428908073648784,1.0,4/59,1.32%,APOE;SPP1;CSF1;CST3
67,response to tumor necrosis factor (GO:0034612),0.7494587923809207,1.5827745176800476,0.014127144298688193,0.0707871907115023,0.882,7/25,9.31%,CCL3;CCL4;ZFP36;RPS3;NFE2L2;ZFP36L1;CXCL16
85,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.7593768452141749,1.553632400143681,0.014227642276422764,0.07746806865259014,0.947,11/23,13.99%,CTSL;CTSS;FCER1G;CD74;CLTA;FCGR2B;LGMN;IFI30;CANX;CAPZB;CTSE
87,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.7593768452141749,1.553632400143681,0.014227642276422764,0.07746806865259014,0.947,11/23,13.99%,CTSL;CTSS;FCER1G;CD74;CLTA;FCGR2B;LGMN;IFI30;CANX;CAPZB;CTSE
86,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.7593768452141749,1.553632400143681,0.014227642276422764,0.07746806865259014,0.947,11/23,13.99%,CTSL;CTSS;FCER1G;CD74;CLTA;FCGR2B;LGMN;IFI30;CANX;CAPZB;CTSE
73,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.7445830295181596,1.5763697773021375,0.015166835187057633,0.07069530213349179,0.898,9/24,11.06%,IL1B;TNF;IGF1;MCL1;LGALS3;GPX1;TNFAIP3;DDX3X;SERPINE1
126,positive regulation of cell differentiation (GO:0045597),0.6963609787428986,1.4908977424345402,0.016016016016016016,0.10316416425810317,0.998,14/37,14.72%,CSF1;IL1B;LPL;ID2;ZFP36;IGF1;BTG1;CEBPB;ZFP36L1;SDCBP;TGFBR2;HSP90AB1;ATP6AP1;CDC42
116,cellular response to organic cyclic compound (GO:0071407),0.7160810105293663,1.509439128200635,0.0160481444332999,0.09316741945630419,0.992,8/31,9.11%,SPP1;CCL3;ACTB;IL1B;TNF;ZFP36L1;EGR1;RAP1B
106,protein processing (GO:0016485),0.7313880840246714,1.5275378649684217,0.016243654822335026,0.0844230916277605,0.982,4/21,5.70%,CTSL;CTSS;SRGN;CTSH
267,cytokine-mediated signaling pathway (GO:0019221),0.5723028115354379,1.2490977712792173,0.017,0.33414036902958383,1.0,70/166,25.34%,CCL3;CCL4;CSF1;IL1B;TMSB4X;FCER1G;B2M;RPLP0;TNF;NFKBIA;JUNB;CDKN1A;MCL1;SQSTM1;ITGAX;FOS;OSM;IFITM3;TNFSF9;CXCL2;EGR1;SOCS3;PIM1;ITGB2;RAP1B;CRLF2;UBC;UBB;IRF1;IFI30;MAP3K8;MSN;CSF2RA;CSF1R;CANX;VIM;LCP1;CDC42;PTPN6;STAT3;CSF2RB;CD86;HNRNPA2B1;GRB2;ANXA2;YWHAZ;ADIPOR1;CSF3R;PTGS2;NFKB1;CD44;P4HB;PRKCD;IL10RA;MIF;BST2;HSPA8;SOD2;TRIM25;TNFRSF1B;PTK2B;PITPNA;PTAFR;PSMB6;PSME1;SOD1;PSMB1;PSMB4;PDGFB;EIF5A
49,response to interleukin-1 (GO:0070555),0.7830593800933434,1.6102880887653979,0.017471736896197326,0.06844854001016336,0.779,4/17,3.56%,CCL3;CCL4;IL1B;SIRPA
271,"positive regulation of transcription, DNA-templated (GO:0045893)",0.5662227175114818,1.2423043408810912,0.019,0.34260130693437013,1.0,42/164,19.01%,APOE;SPP1;IL1B;ID2;TNF;NFKBIA;TLR2;IGF1;JUNB;NFE2L2;CEBPB;SQSTM1;CD74;FOS;OSM;IER2;LITAF;CD81;NR4A1;DDX3X;EGR1;ATF3;UBC;UBB;SLC11A1;IRF1;SERPINE1;IER5;STAT3;YBX1;MAFF;CD86;NPM1;FGFR2;DAB2;CDK8;GLMP;SNX5;ACTR2;ZEB2;NFKB1;SBNO2
113,negative regulation of Wnt signaling pathway (GO:0030178),0.7223907494892472,1.5129877779606324,0.01919191919191919,0.0919618656618253,0.991,2/26,2.88%,APOE;RACK1
80,positive regulation of phagocytosis (GO:0050766),0.7573119079439709,1.5664917492964905,0.019348268839103868,0.07240443744125281,0.916,9/21,9.89%,TREM2;IL1B;CLEC7A;FCER1G;TNF;SIRPA;PTPRC;FCGR2B;SLC11A1
68,lipid transport (GO:0006869),0.7515638309554862,1.58115458511207,0.01940755873340143,0.0713077219204182,0.886,2/19,1.61%,APOE;NPC2
89,positive regulation of cell projection organization (GO:0031346),0.7639748200624471,1.549520114810825,0.019487179487179488,0.07917161767919202,0.954,1/17,0.05%,APOE
84,neutrophil migration (GO:1990266),0.7594379696109048,1.5608184500940978,0.01954732510288066,0.07347222208331793,0.926,8/17,13.60%,CCL3;CCL4;FCER1G;LGALS3;CXCL2;ITGB2;PDE4B;S100A9
82,granulocyte chemotaxis (GO:0071621),0.7594379696109048,1.5608184500940978,0.01954732510288066,0.07347222208331793,0.926,8/17,13.60%,CCL3;CCL4;FCER1G;LGALS3;CXCL2;ITGB2;PDE4B;S100A9
83,neutrophil chemotaxis (GO:0030593),0.7594379696109048,1.5608184500940978,0.01954732510288066,0.07347222208331793,0.926,8/17,13.60%,CCL3;CCL4;FCER1G;LGALS3;CXCL2;ITGB2;PDE4B;S100A9
234,positive regulation of intracellular signal transduction (GO:1902533),0.5904189140746474,1.289548396691614,0.02,0.29506534674541657,1.0,33/126,16.62%,CCL3;CCL4;CD14;TREM2;IL1B;CLEC7A;TNF;RPS3;RACK1;RPS15;TLR2;IGF1;LAPTM5;AXL;RPL23;CD74;RPS20;OSM;LITAF;PTPRC;DDX3X;SHISA5;HSP90AB1;TLR7;S100A9;OSBPL8;PTPN6;CD86;IQGAP1;GRB2;FGFR2;S100A8;RPL37
246,negative regulation of apoptotic process (GO:0043066),0.5882240509382347,1.2807163783833226,0.02,0.297403630592517,1.0,23/122,11.84%,APOE;TPT1;TREM2;TNF;NFKBIA;GRN;IGF1;AXL;MCL1;SQSTM1;CD74;CTSH;ANXA5;GPX1;PTMA;DDX3X;PLAUR;PIM1;UBC;UBB;LGMN;PPT1;ARHGDIA
44,negative regulation of defense response (GO:0031348),0.7956541453651298,1.6156295844472242,0.02066115702479339,0.07045527485649672,0.758,3/15,7.50%,APOE;SIRPA;TNFAIP3
123,regulation of neuron projection development (GO:0010975),0.7223131105786592,1.4997545149622957,0.022244691607684528,0.096855729480596,0.998,1/25,0.05%,APOE
149,response to lipopolysaccharide (GO:0032496),0.6669113332620606,1.42619691421788,0.024072216649949848,0.16159412635891324,1.0,20/43,19.88%,CD14;CD68;IL1B;ZFP36;SIRPA;AXL;TNFAIP3;CXCL2;SLC11A1;SERPINE1;MAPKAPK2;CD274;PDE4B;S100A9;VIM;CD86;S100A8;NFKB1;SBNO2;NLRP3
120,negative regulation of protein binding (GO:0032091),0.7304359720915682,1.5032040046655377,0.024640657084188913,0.09572971139741415,0.995,6/19,9.21%,CTSZ;ACTB;B2M;RACK1;CDKN1A;LRPAP1
103,ribosome assembly (GO:0042255),0.7529276996787465,1.5343593202192192,0.02476780185758514,0.08081638194318201,0.974,12/18,19.30%,RPS5;RPS14;RPLP0;RPS15;RPSA;RPS19;DDX3X;RPL6;RPL3;NPM1;RPL11;RPS28
204,positive regulation of protein phosphorylation (GO:0001934),0.6161738717551518,1.336947783262559,0.025,0.24423421184936714,1.0,19/72,12.67%,TREM2;CSF1;IL1B;TNF;RACK1;IGF1;CDKN1A;CD74;CALM1;OSM;SDCBP;CD81;PTPRC;DDX3X;PLAUR;NRP1;HSP90AB1;GPNMB;CSF1R
93,positive regulation of cell death (GO:0010942),0.7613278216909344,1.5424813982432708,0.025933609958506226,0.08178315712665855,0.969,7/16,8.97%,TYROBP;TNF;C1QA;FOS;FCGR2B;EGR1;ITGB2
100,positive regulation of protein transport (GO:0051222),0.7467816280612875,1.5364256607897604,0.02672147995889003,0.0813973860449445,0.972,4/20,3.12%,TREM2;TNF;RACK1;IGF1
105,positive regulation of kinase activity (GO:0033674),0.7444481920718374,1.529244790472557,0.029411764705882353,0.08368161360669944,0.979,10/20,16.28%,TREM2;CSF1;TNF;AXL;CDKN1A;CD74;PTPRC;CSF1R;IQGAP1;FGFR2
115,negative regulation of response to external stimulus (GO:0032102),0.73702190090096,1.510897756838622,0.03048780487804878,0.09255672686181576,0.992,3/20,7.50%,APOE;SIRPA;TNFAIP3
195,organelle organization (GO:0006996),0.6319666769177433,1.3453643881211241,0.031,0.24019004912964143,1.0,2/55,0.34%,APOE;CCL3
235,regulation of cell migration (GO:0030334),0.5940853365166993,1.287854987439527,0.032,0.2975094888014839,1.0,31/83,23.34%,CCL3;CSF1;IL1B;CLEC7A;TMSB4X;RACK1;GRN;IGF1;SERPINE2;ITGAX;CD74;CTSH;SDCBP;CXCL16;SERPINE1;CLIC4;GPNMB;CSF1R;STAT3;SGK1;HSPA5;DAB2;PLAU;MIF;BST2;FGR;SOD2;ACTG1;PTK2B;FLNA;SPAG9
127,cellular response to organic substance (GO:0071310),0.7046591716617139,1.4902036113793158,0.03225806451612903,0.10299884953896549,0.998,9/25,15.55%,CCL3;IL1B;TNF;RACK1;TGFBR2;CSF1R;PTPN6;STAT3;RAMP1
91,amyloid fibril formation (GO:1990000),0.7577454953168338,1.5445488018531481,0.03249475890985325,0.0817461414545517,0.966,5/15,9.75%,CST3;ITM2B;B2M;UBC;UBB
117,negative regulation of cellular catabolic process (GO:0031330),0.7297485256546425,1.5058932316226397,0.034161490683229816,0.09574375844230952,0.994,4/18,4.63%,TREM2;CST3;TIMP2;MCL1
197,innate immune response (GO:0045087),0.6296721489240338,1.3448797389489406,0.035,0.2386242199449283,1.0,12/57,9.89%,TYROBP;TREM2;CLEC7A;FCER1G;B2M;TLR2;CYBB;CD74;DDX3X;IFITM3;CXCL16;SLC11A1
141,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6932974500265208,1.457444883384971,0.035317860746720484,0.12771620779797013,1.0,7/25,13.21%,CD14;TNF;NFKBIA;TLR2;UBC;UBB;TLR7
178,positive regulation of cell migration (GO:0030335),0.6404877972784608,1.3760309259311312,0.036,0.20713001203058637,1.0,19/54,16.91%,CCL3;CSF1;IL1B;CLEC7A;RACK1;GRN;IGF1;ITGAX;CTSH;SDCBP;PTPRC;CXCL16;NRP1;GPNMB;CSF1R;PFN1;STAT3;HSPA5;DAB2
165,positive regulation of cell motility (GO:2000147),0.6531509212971229,1.4035309412965697,0.036036036036036036,0.17761220114961382,1.0,22/46,23.34%,CCL3;CSF1;IL1B;CLEC7A;RACK1;GRN;IGF1;ITGAX;CTSH;SDCBP;CXCL16;GPNMB;CSF1R;STAT3;HSPA5;DAB2;PLAU;FGR;SOD2;ACTG1;PTK2B;SPAG9
134,defense response to bacterium (GO:0042742),0.7130260923649278,1.4782447701444683,0.03654822335025381,0.11025332042309371,0.999,14/22,21.49%,TREM2;MPEG1;FCER1G;TLR2;CEBPB;RPS19;ANXA3;SLC11A1;SERPINE1;S100A9;S100A8;RPL39;PRKCD;FGR
108,ribonucleoprotein complex biogenesis (GO:0022613),0.7648962110970695,1.5215653292587785,0.036610878661087864,0.08779590844471606,0.985,12/15,20.47%,RPS15;RPS24;RPS19;RPL26;RPL14;RPL7;RPS25;NPM1;RPS17;RPL11;RPS28;RPL35A
200,positive regulation of apoptotic process (GO:0043065),0.6280667447956084,1.3420285752943837,0.037037037037037035,0.24021702909022902,1.0,11/53,9.75%,CCL3;TNF;RPS3;RACK1;GRN;BTG1;GADD45B;SQSTM1;DDX3X;UBC;UBB
114,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.7312860050786313,1.511250364958649,0.03802672147995889,0.09305228146024692,0.992,4/18,8.04%,CST7;TNF;GPX1;DDX3X
156,regulation of cytokine production (GO:0001817),0.6660568219058135,1.4189608442548858,0.039,0.164457426426755,1.0,20/35,24.71%,TREM2;SRGN;TNF;SIRPA;PLD3;CADM1;PTPRC;FCGR2B;SLC11A1;MAPKAPK2;GPNMB;CD47;NPTN;PTGER4;MIF;FGR;TNFRSF1B;SOD1;ATP2B1;LYN
153,cellular response to interferon-gamma (GO:0071346),0.6765607926574517,1.422640680212755,0.04036326942482341,0.1623998411971877,1.0,5/28,3.56%,CCL3;CCL4;B2M;TLR2;SIRPA
131,response to molecule of bacterial origin (GO:0002237),0.6996090384065267,1.4796463147005725,0.04036326942482341,0.11114983763197715,0.999,9/22,16.47%,CD14;IL1B;TNFAIP3;FCGR2B;CXCL2;SLC11A1;MAPKAPK2;S100A9;S100A8
152,positive regulation of protein-containing complex assembly (GO:0031334),0.6797791507776368,1.424421432478014,0.04124748490945674,0.16103726475627098,1.0,10/28,14.28%,CLEC7A;TNF;RPS3;PLEK;RACK1;LGALS3;DDX3X;RAP1B;ABCA1;LCP1
155,positive regulation of angiogenesis (GO:0045766),0.672472256061517,1.4195164201178303,0.04229607250755287,0.16470892068302737,1.0,8/26,11.06%,IL1B;GRN;BTG1;ITGAX;PKM;CTSH;ANXA3;SERPINE1
124,calcium ion transport (GO:0006816),0.7306355203827876,1.4992531445582338,0.04266389177939646,0.096555122951981,0.998,2/16,0.88%,CCL3;TPT1
140,negative regulation of binding (GO:0051100),0.7063131583015646,1.4582925839329242,0.04374364191251272,0.12762699086706583,1.0,6/20,9.21%,CTSZ;ACTB;NFKBIA;RACK1;CDKN1A;LRPAP1
188,regulation of cell cycle (GO:0051726),0.6330351014560209,1.3592026438524516,0.04613841524573721,0.22328767382068299,1.0,17/45,17.06%,ID2;RACK1;JUNB;DUSP1;GADD45B;RPL23;CDKN1A;SDCBP;NR4A1;PTPRC;IRF1;HSP90AB1;STAT3;IQGAP1;RPS15A;FGFR2;CALR
139,protein maturation (GO:0051604),0.713345039946029,1.4651851702487337,0.047866805411030174,0.12042290980013065,1.0,2/16,1.02%,CTSS;SRGN
174,extracellular matrix organization (GO:0030198),0.6490797712892179,1.3815866277540738,0.04904904904904905,0.20238639400850889,1.0,15/37,19.83%,SPP1;CTSL;CTSS;TIMP2;ITGAX;ADAMTS1;ITGB2;SERPINE1;CD47;LCP1;CAPG;ITGB5;CD44;CAPNS1;P4HB
138,cellular response to peptide (GO:1901653),0.719849032626995,1.4661854713674192,0.05015353121801433,0.12006670230403567,1.0,8/18,15.20%,TREM2;IGF1;RPL23;ZFP36L1;FCGR2B;LGMN;VIM;LRP1
159,response to lipid (GO:0033993),0.6777895098561973,1.4154218697095151,0.050352467270896276,0.1665243605142896,1.0,8/23,16.47%,SPP1;IL1B;CTSH;SLC11A1;MAPKAPK2;S100A9;STAT3;S100A8
157,cellular response to growth factor stimulus (GO:0071363),0.664126479611217,1.4162233758248188,0.05110220440881764,0.16745002290441785,1.0,9/29,11.65%,EEF1A1;ZFP36;RACK1;ZFP36L1;NR4A1;NRP1;TGFBR2;LGMN;MAPKAPK2
148,positive regulation of vasculature development (GO:1904018),0.6824734459232382,1.426971077569026,0.0525783619817998,0.16179143933024615,1.0,7/21,11.06%,IL1B;GRN;BTG1;ITGAX;CTSH;ANXA3;SERPINE1
168,regulation of protein binding (GO:0043393),0.6687351533735039,1.3964326609467448,0.05740181268882175,0.18544380053170031,1.0,11/26,20.03%,CTSZ;ACTB;B2M;RACK1;CDKN1A;LRPAP1;LRP1;TMBIM6;DAB2;RPL11;PRKCD
136,regulation of kinase activity (GO:0043549),0.7389125920816917,1.4707162346943172,0.05779153766769866,0.11666315804525511,1.0,4/15,5.26%,EEF1A1;TREM2;AXL;CD74
150,regulation of JNK cascade (GO:0046328),0.6991898753058347,1.4258011888574234,0.058762886597938144,0.16100424480450662,1.0,5/19,7.99%,IL1B;SIRPA;GADD45B;SDCBP;FCGR2B
171,positive regulation of protein kinase activity (GO:0045860),0.656115516306868,1.3897259707569738,0.061,0.192399718941902,1.0,13/31,15.94%,CSF1;TNF;CDKN1A;CALM1;PTPRC;DDX3X;EGR1;SLC11A1;TGFBR2;HSP90AB1;CSF1R;IQGAP1;PTPN1
190,regulation of angiogenesis (GO:0045765),0.6401882666220176,1.3577026820088733,0.062186559679037114,0.2232616738586638,1.0,10/31,11.99%,IL1B;GRN;BTG1;ITGAX;CTSH;ANXA3;TNFAIP3;ADAMTS1;SERPINE1;GPNMB
164,regulation of protein catabolic process (GO:0042176),0.6781588530444047,1.4073552058853187,0.06224489795918367,0.17314072268525874,1.0,4/22,7.50%,EEF1A1;TNF;CTSA;TNFAIP3
219,positive regulation of phosphorylation (GO:0042327),0.6171280973827494,1.319629197964889,0.064,0.257240537464245,1.0,17/50,18.13%,TREM2;IL1B;TNF;RACK1;IGF1;AXL;CD74;SDCBP;PLAUR;NRP1;GPNMB;CSF1R;PFKFB3;NPTN;FGFR2;DAB2;ERP29
183,regulation of programmed cell death (GO:0043067),0.6453049452783561,1.3687340088405435,0.06639839034205232,0.21312154659489002,1.0,4/33,2.73%,CTSB;TPT1;TNF;RPS3
154,cellular calcium ion homeostasis (GO:0006874),0.6880369843995098,1.4205415756205602,0.06673511293634497,0.16436703261940863,1.0,2/19,0.88%,CCL3;TPT1
146,myeloid leukocyte differentiation (GO:0002573),0.6944393909687323,1.4415774972623299,0.06896551724137931,0.14399063897310257,1.0,7/22,14.72%,TYROBP;TREM2;CSF1;CDKN1A;TGFBR2;CSF1R;CDC42
196,negative regulation of multicellular organismal process (GO:0051241),0.6347670115127062,1.3449449631563994,0.07007007007007007,0.2396854253770014,1.0,13/35,17.50%,SRGN;IL1B;TNF;GRN;RPS19;FCGR2B;LRPAP1;SLC11A1;GPNMB;NPTN;PTGER4;CALR;ADIPOR1
217,regulation of canonical Wnt signaling pathway (GO:0060828),0.6192367359901073,1.3215481190469875,0.07107107107107107,0.25625586529198446,1.0,1/41,0.05%,APOE
170,regulation of protein localization to plasma membrane (GO:1903076),0.6616882923045388,1.390727331902927,0.07373737373737374,0.1919623078161676,1.0,5/23,5.80%,TREM2;ACTB;TNF;SQSTM1;LGALS3
158,positive regulation of secretion by cell (GO:1903532),0.6856213493002582,1.4156671565382508,0.0745658835546476,0.16726565439199756,1.0,3/19,3.12%,TREM2;IL1B;IGF1
224,cellular response to interleukin-1 (GO:0071347),0.6160812280154757,1.3096450487966929,0.075,0.2691369818438735,1.0,9/45,9.75%,CCL3;CCL4;IL1B;NFKBIA;SIRPA;SQSTM1;EGR1;UBC;UBB
143,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6974205585682444,1.4517795007949745,0.07510288065843622,0.13303675010395288,1.0,4/17,7.50%,TNF;RACK1;LAPTM5;TNFAIP3
226,negative regulation of intracellular signal transduction (GO:1902532),0.6143134381121244,1.307265819568108,0.07622868605817452,0.271249320572322,1.0,9/46,8.09%,TREM2;TMSB4X;PLEK;RACK1;DUSP1;MCL1;TNFAIP3;DDX3X;PLAUR
220,protein stabilization (GO:0050821),0.622347592707832,1.3147985419890489,0.07907907907907907,0.26494977659691943,1.0,16/37,23.00%,TYROBP;GRN;IGF1;RPL23;CDKN1A;ATP1B3;LAMP2;HSP90AB1;PFN1;CALR;GLMP;RPL11;PRKCD;MFSD1;GNAQ;FLNA
173,positive regulation of type I interferon production (GO:0032481),0.6681493417030505,1.389170537857854,0.082389289392379,0.1910149579589847,1.0,5/19,13.21%,CD14;TLR2;DDX3X;IRF1;TLR7
172,cellular response to reactive oxygen species (GO:0034614),0.6994637581209268,1.3895553997475256,0.08247422680412371,0.19154534809694623,1.0,5/16,7.50%,RPS3;NFE2L2;SIRPA;FOS;TNFAIP3
202,regulation of immune response (GO:0050776),0.631839788263151,1.3394503343859856,0.08249496981891348,0.24226018075905215,1.0,7/34,10.62%,TYROBP;TREM2;B2M;CD81;FCGR2B;ITGB2;IRF1
198,negative regulation of apoptotic signaling pathway (GO:2001234),0.6415144388012721,1.3440714576095656,0.08266129032258064,0.2389110247354179,1.0,7/26,8.09%,TNF;IGF1;MCL1;LGALS3;GPX1;DDX3X;PLAUR
163,epithelial cell differentiation (GO:0030855),0.6967579494322502,1.4075824003460256,0.08324768756423433,0.17385137793921573,1.0,7/16,16.91%,CTSB;LGALS3;TAGLN2;TPP1;FGFR2;PGK1;DAB2
181,receptor metabolic process (GO:0043112),0.6691623380477346,1.3723407955452267,0.0836734693877551,0.2097668316935175,1.0,10/20,20.22%,CD9;FCER1G;CD81;ITGB2;LGMN;LRP1;RAMP1;GRB2;SH3GLB1;PICALM
194,regulation of cell differentiation (GO:0045595),0.6347278061465259,1.3468311753438487,0.0841683366733467,0.23843358983981244,1.0,7/31,7.65%,CSF1;ID2;TNF;CEBPB;LGALS3;ZFP36L1;DDX5
222,positive regulation of protein modification process (GO:0031401),0.6135009588315091,1.3109131412414305,0.08517034068136273,0.2693052642557038,1.0,14/41,18.13%,TREM2;IL1B;TNF;RACK1;CD74;CALM1;DDX3X;PLAUR;GPNMB;CSF1R;NPTN;RAMP1;DAB2;ERP29
203,apoptotic process (GO:0006915),0.6294534900305586,1.3387878541623561,0.08625877632898696,0.24214725218188327,1.0,8/32,10.82%,CD14;IL1B;NFKBIA;TLR2;IER3;ITGB2;IRF1;TGFBR2
167,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6743569401409054,1.4016114755267446,0.08904810644831115,0.17827161981979336,1.0,5/19,8.09%,TPT1;NFE2L2;MCL1;DDX3X;PLAUR
169,negative regulation of autophagy (GO:0010507),0.6849947208946896,1.3960281192593305,0.09214659685863874,0.18500126821111987,1.0,3/15,4.63%,TREM2;CTSA;MCL1
201,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.6286708067277496,1.3418780273966056,0.09227683049147442,0.23931192901936715,1.0,17/32,25.24%,TREM2;TNF;IGF1;CD74;OSM;CD81;PTPRC;SOCS3;NRP1;CSF1R;STAT3;PTPN1;CD44;MIF;PTK2B;LYN;PDGFB
175,positive regulation of protein secretion (GO:0050714),0.6728770215183899,1.3791421719187986,0.09342915811088295,0.20536820285464383,1.0,4/18,9.36%,TREM2;TLR2;IGF1;HCAR2
229,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.61434966588175,1.3040716221713555,0.0940940940940941,0.2734814520258425,1.0,15/41,19.88%,IL1B;CLEC7A;TNF;RPS3;NFKBIA;TLR2;RAB7B;UBC;UBB;S100A9;STAT3;NPM1;S100A8;NFKB1;NLRP3
162,cellular metal ion homeostasis (GO:0006875),0.6928214603068219,1.4090556809175212,0.09465020576131687,0.1726801921926914,1.0,3/15,6.24%,CCL3;TPT1;ATP1B3
166,positive regulation of catabolic process (GO:0009896),0.6927574247914036,1.4034623378490862,0.09479166666666666,0.17667318769839943,1.0,3/15,7.50%,IL1B;TNF;TNFAIP3
263,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5815795930839953,1.2563900767702796,0.096,0.32355637905887824,1.0,9/57,9.41%,TREM2;IL1B;CLEC7A;TNF;SQSTM1;CD74;LITAF;TNFAIP3;SHISA5
205,positive regulation of GTPase activity (GO:0043547),0.6277984677399775,1.3334026851408995,0.09619238476953908,0.24933227967708207,1.0,3/31,2.88%,CCL3;CCL4;RACK1
207,regulation of GTPase activity (GO:0043087),0.6351508098272033,1.332714774858435,0.09919839679358718,0.2482978788315927,1.0,3/30,2.88%,CCL3;CCL4;RACK1
179,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.6706463801014917,1.3759904477312015,0.09938524590163934,0.20605013475552272,1.0,3/16,5.80%,TNF;IGF1;LGALS3
261,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.5898967432382638,1.2596425720306765,0.1,0.3198503373593498,1.0,17/52,19.88%,IL1B;CLEC7A;TNF;RPS3;NFKBIA;TLR2;ANXA3;RAB7B;UBC;UBB;S100A9;STAT3;NPM1;S100A8;NFKB1;CAMK1D;NLRP3
256,positive regulation of cellular biosynthetic process (GO:0031328),0.5913023408248006,1.2686440779784525,0.10341365461847389,0.30878042393261207,1.0,14/45,18.52%,IL1B;CLEC7A;TNF;IGF1;RPS4X;EEF2;RPL26;DDX3X;EGR1;HSP90AB1;VIM;NPM1;ZEB2;PTGS2
180,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6686230341534187,1.3733201503211432,0.10369609856262833,0.20940080521777424,1.0,5/17,10.82%,TYROBP;CLEC7A;CDKN1A;ITGB2;TGFBR2
176,ribosomal large subunit biogenesis (GO:0042273),0.6828219871463667,1.3786560208594842,0.10390946502057613,0.20501531414936552,1.0,10/16,20.91%,RPLP0;RPL26;RPL14;RPL7;RPL6;RPL3;NPM1;RPL11;RPL35A;RPL10A
186,iron ion homeostasis (GO:0055072),0.6498845924043423,1.3595903386990538,0.10975609756097561,0.2250033917444645,1.0,6/19,17.35%,FTH1;B2M;SLC11A1;ATP6AP1;ATP6V1A;ATP6V1G1
244,positive regulation of cellular protein metabolic process (GO:0032270),0.6097447997180814,1.2813562246225307,0.11022044088176353,0.29865090799213506,1.0,9/32,16.13%,CSF1;NFKBIA;RPS4X;EEF2;RPL26;DDX3X;MSN;VIM;NPM1
225,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.6150155672660671,1.3084845179941371,0.11055276381909548,0.2701144143049261,1.0,6/30,8.04%,CLEC7A;TNF;RPS3;RACK1;LAPTM5;DDX3X
182,regulation of interferon-beta production (GO:0032648),0.6809993306546611,1.3720298273549143,0.11122770199370409,0.20909198027208126,1.0,5/15,13.21%,TLR2;SIRPA;DDX3X;IRF1;TLR7
193,receptor internalization (GO:0031623),0.6644283923562295,1.3558334791171505,0.118488253319714,0.222980524010301,1.0,7/17,16.23%,CD9;FCER1G;CD81;ITGB2;LRP1;RAMP1;GRB2
215,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.624963155230382,1.3236165864691438,0.11871227364185111,0.2549725577678657,1.0,13/27,22.71%,TREM2;IGF1;CD74;OSM;CD81;PTPRC;ITGB2;NRP1;PTPN6;CD44;PRKCD;MIF;PTK2B
329,NIK/NF-kappaB signaling (GO:0038061),-0.23741362290227047,-1.1271540291696793,0.125,0.8957107362364326,0.785929648241206,26/26,76.61%,MAP3K14;PSMC3;RELA;PSMD14;PSMA1;PSMD4;PSMA2;ZFP91;PSMB2;AKT1;FBXW11;PSMB3;RELB;PSMB8;IRAK1;MALT1;REL;PSMB9;BIRC3;PSMD8;PSMA7;PSMA6;PSMB4;PSMB1;PSME1;PSMB6
300,negative regulation of programmed cell death (GO:0043069),0.5481648296372265,1.1882857505675888,0.125,0.41859973750151136,1.0,32/94,23.05%,TPT1;TREM2;NFKBIA;IGF1;LAPTM5;AXL;MCL1;SQSTM1;CD74;CTSH;ANXA5;PTMA;DDX3X;PLAUR;PIM1;UBC;UBB;PPT1;ARHGDIA;PRDX5;TMBIM6;NPM1;HSPA5;DAB2;YWHAZ;NFKB1;CD44;HNRNPK;MIF;PTK2B;FLNA;ARF4
185,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6687080735207693,1.3607545009726107,0.1256544502617801,0.22419022385358647,1.0,7/15,17.88%,CD52;CCRL2;C3AR1;C5AR1;NPTN;PTGER4;FIS1
233,cellular response to interleukin-12 (GO:0071349),0.62288634494989,1.2936474725497493,0.12740141557128412,0.28824115833557573,1.0,17/24,29.09%,RPLP0;SIRPA;RAP1B;MSN;CD47;LCP1;CDC42;HNRNPA2B1;ANXA2;P4HB;MIF;SOD2;PITPNA;SOD1;TALDO1;ARF1;LMNB1
227,regulation of protein ubiquitination (GO:0031396),0.6269418977763677,1.3056203681581713,0.12903225806451613,0.2730532046472724,1.0,6/25,11.55%,RPS3;LAPTM5;SQSTM1;TNFAIP3;UBB;HSP90AB1
243,response to cytokine (GO:0034097),0.5937081151596842,1.2815569760399077,0.12912912912912913,0.2995790520859384,1.0,12/40,14.86%,IL1B;TIMP2;MCL1;CD74;IFITM3;CXCL16;SLC11A1;MAPKAPK2;CSF1R;CD274;PTPN6;STAT3
218,positive regulation of stress-activated MAPK cascade (GO:0032874),0.6440539142900468,1.3203723080455805,0.13052415210688592,0.25710169781954867,1.0,4/18,7.99%,IL1B;GADD45B;SDCBP;FCGR2B
239,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6093665779297026,1.286621411505322,0.1306532663316583,0.2948038873412113,1.0,10/30,15.94%,TNF;RACK1;AXL;CD74;TNFAIP3;PTPRC;SOCS3;HSP90AB1;PTPN6;PTPN1
334,regulation of transcription by RNA polymerase II (GO:0006357),0.5101775731273557,1.1202354319744476,0.131,0.52123639869712,1.0,55/225,20.32%,APOE;ID2;ZFP36;RPS14;TNF;NFKBIA;TLR2;IGF1;JUNB;NFE2L2;CEBPB;RPL23;CDKN1A;SQSTM1;FOS;OSM;IER2;CREG1;LITAF;SDCBP;CD81;NR4A1;DDX5;DDX3X;EGR1;ATF3;UBC;UBB;SLC11A1;IRF1;TGIF1;SERPINE1;IER5;CSF1R;KLF13;UBE2D3;CCNL1;STAT3;YBX1;MAFF;NPM1;FGFR2;IFRD1;DAB2;CALR;CDK8;GLMP;ACTR2;ZEB2;NFKB1;SBNO2;BRD2;NLRP3;BHLHE40;HNRNPK
259,negative regulation of signal transduction (GO:0009968),0.5984087499237856,1.262427373556788,0.13113113113113112,0.31703309672264224,1.0,13/38,17.06%,IL1B;TNF;PLEK;RACK1;TNFAIP3;PTPRC;LRPAP1;LGMN;CD47;LRP1;TMBIM6;PTPN1;CALR
187,positive regulation of cell growth (GO:0030307),0.6608091484100985,1.3594166202665143,0.13199577613516367,0.2240590523729952,1.0,7/15,16.47%,IGF1;SDCBP;DDX3X;CXCL16;S100A9;CDC42;S100A8
216,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.6421700026909267,1.3222624253656874,0.13347022587268995,0.2561752183710499,1.0,13/18,28.85%,RACK1;MCL1;DDX3X;PLAUR;S100A9;S100A8;FIS1;P4HB;PMAIP1;BCL2L1;SGMS1;HERPUD1;PYCARD
251,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6064171162539213,1.2737855694878197,0.13380281690140844,0.3050514428261342,1.0,3/32,2.05%,TYROBP;CLEC7A;FCER1G
250,cellular response to lectin (GO:1990858),0.6064171162539213,1.2737855694878197,0.13380281690140844,0.3050514428261342,1.0,3/32,2.05%,TYROBP;CLEC7A;FCER1G
249,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6064171162539213,1.2737855694878197,0.13380281690140844,0.3050514428261342,1.0,3/32,2.05%,TYROBP;CLEC7A;FCER1G
209,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6410789333258046,1.3303807003262498,0.13477366255144033,0.2499352712574275,1.0,6/18,14.77%,ID2;CDKN1A;DDX3X;ADAMTS1;GPNMB;PTPN6
238,positive regulation of cellular amide metabolic process (GO:0034250),0.6038335724754014,1.2867937957497213,0.13480885311871227,0.29578103010704027,1.0,11/28,20.42%,TNF;RACK1;RPS4X;EEF2;RPL26;DDX3X;VIM;NPM1;PRKCD;PICALM;ABCG1
228,positive regulation of protein localization to membrane (GO:1905477),0.6249793949862916,1.3043887210273177,0.13494461228600202,0.27403093302810805,1.0,9/25,17.88%,TREM2;TNF;SQSTM1;LGALS3;CD81;ITGB2;LRP1;YWHAZ;FIS1
252,regulation of MAPK cascade (GO:0043408),0.5991854786920301,1.2717295967869104,0.13527054108216433,0.3076321696576045,1.0,11/33,16.96%,IL1B;IGF1;DUSP1;LAPTM5;CD74;OSM;PTPRC;PTPN6;IQGAP1;FGFR2;YWHAZ
287,regulation of protein phosphorylation (GO:0001932),0.5640477196426467,1.2060300759714842,0.137,0.397037238188606,1.0,16/57,18.13%,TREM2;IL1B;TNF;RACK1;SIRPA;CEBPB;CD74;PLAUR;ITGB2;ATF3;GPNMB;CSF1R;NPTN;NPM1;DAB2;ERP29
221,glycolipid metabolic process (GO:0006664),0.643285194629003,1.31125977324759,0.13789581205311544,0.26999631147091513,1.0,10/19,22.12%,CTSA;HEXA;PSAP;HEXB;GM2A;FUCA1;GLTP;GLB1;ASAH1;ST8SIA6
214,iron ion transport (GO:0006826),0.6357359100618513,1.3238610255071561,0.13863404689092762,0.255716187196675,1.0,6/20,17.35%,FTH1;ATP6V0C;SLC11A1;ATP6AP1;ATP6V1A;ATP6V1G1
208,cellular iron ion homeostasis (GO:0006879),0.6411445498565685,1.3326209462204022,0.13891726251276812,0.24727513877972077,1.0,5/17,17.35%,FTH1;SLC11A1;ATP6AP1;ATP6V1A;ATP6V1G1
210,glycosphingolipid metabolic process (GO:0006687),0.6590161732391208,1.3295291612791176,0.13946280991735538,0.2501565298086712,1.0,8/16,20.66%,CTSA;HEXA;PSAP;HEXB;GM2A;GLTP;GLB1;ASAH1
223,negative regulation of translation (GO:0017148),0.638410837916755,1.3106517830533466,0.14343434343434344,0.26852737455053327,1.0,5/20,8.04%,RPS3;RACK1;BTG2;PATL2;DDX3X
212,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6498858627446334,1.324506918127568,0.1496881496881497,0.25697749253102103,1.0,10/15,26.66%,RPS3;RACK1;UBB;S100A9;S100A8;FIS1;PMAIP1;SOD1;EIF5A;BCL2L1
297,MAPK cascade (GO:0000165),0.5574249857007059,1.1931720115878,0.15,0.4124542313839021,1.0,19/67,18.81%,CCL3;IL1B;ZFP36;TNF;IGF1;CALM1;CTSH;ZFP36L1;UBC;UBB;MAPKAPK2;MAP3K8;CSF2RA;CSF2RB;GRB2;FGFR2;PTGER4;NFKB1;RASGRP3
236,negative regulation of cell differentiation (GO:0045596),0.6214559659933606,1.2874205573548014,0.15030674846625766,0.2970107864647175,1.0,8/21,22.71%,ID2;TNF;NFKBIA;ABCA1;CALR;ADIPOR1;ABCG1;PTK2B
213,regulation of innate immune response (GO:0045088),0.660755549132484,1.3241839304081167,0.15513626834381553,0.2563276443351357,1.0,7/15,15.94%,TREM2;TNFAIP3;FCGR2B;IRF1;HSP90AB1;PTPN6;PTPN1
325,positive regulation of transcription by RNA polymerase II (GO:0045944),0.5187886608553054,1.1351401578478264,0.156,0.5000496224671582,1.0,45/120,25.39%,TNF;NFKBIA;TLR2;IGF1;JUNB;NFE2L2;CEBPB;SQSTM1;FOS;OSM;IER2;LITAF;CD81;NR4A1;DDX3X;EGR1;ATF3;UBC;UBB;SLC11A1;IRF1;SERPINE1;IER5;STAT3;YBX1;MAFF;NPM1;FGFR2;DAB2;CDK8;GLMP;ACTR2;ZEB2;NFKB1;SBNO2;NLRP3;FOSL2;CNBP;ARF4;JUN;ACTR3;KDM6B;PDGFB;EIF5A;EGR2
248,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.6143023330364386,1.2780665549950498,0.1581067472306143,0.2998974006186371,1.0,5/27,6.04%,TREM2;TNF;IGF1;IER3;OSM
211,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.6463384626102896,1.3246834782499526,0.1589958158995816,0.25784421101811283,1.0,5/15,16.47%,TNF;RACK1;LAPTM5;S100A9;S100A8
231,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6335592070946868,1.3030296522538047,0.15934627170582227,0.2729142853086611,1.0,4/20,6.04%,TREM2;TNF;IGF1;OSM
232,regulation of cytosolic calcium ion concentration (GO:0051480),0.6353963119224066,1.2961716139425576,0.16036772216547499,0.2846883772297959,1.0,7/17,17.88%,CD52;CCRL2;C3AR1;C5AR1;NPTN;PTGER4;FIS1
262,Fc-gamma receptor signaling pathway (GO:0038094),0.601441007364145,1.2568182600801567,0.1606425702811245,0.3240220457515738,1.0,16/31,24.81%,ACTB;FCER1G;ARPC2;FCGR2B;ARPC1B;ARPC5;HSP90AB1;CDC42;GRB2;ACTR2;PRKCD;FGR;ACTG1;ACTR3;LYN;WIPF1
237,cellular transition metal ion homeostasis (GO:0046916),0.6136860920874919,1.2873723579430831,0.16093117408906882,0.29586179565228504,1.0,6/21,17.35%,FTH1;ATOX1;SLC11A1;ATP6AP1;ATP6V1A;ATP6V1G1
266,RNA splicing (GO:0008380),-0.2529527559055118,-1.2491077289225478,0.16666666666666666,0.960245848044985,0.5809045226130654,20/20,75.00%,SRSF7;ZCRB1;SNRPG;SRPK2;NONO;SRRM1;DDX39B;DHX15;PPP2R1A;TRA2B;SFPQ;LSM4;FUS;RP9;SF3B2;HNRNPC;RRAGC;SNRPB;SF3B1;MBNL1
289,positive regulation of programmed cell death (GO:0043068),0.5657935258630857,1.203536230202777,0.16816816816816818,0.3998443881283168,1.0,9/47,9.75%,CLEC7A;TNF;RACK1;LAPTM5;GADD45B;SQSTM1;DDX3X;UBC;UBB
274,positive regulation of macromolecule biosynthetic process (GO:0010557),0.584993521892356,1.2385906141014067,0.16916916916916916,0.34650882715217857,1.0,7/34,8.04%,IL1B;TLR2;IGF1;RPS4X;EEF2;RPL26;DDX3X
257,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.6051751265401305,1.2670636329732958,0.1707070707070707,0.3104391418402912,1.0,5/23,12.67%,IL1B;TNF;CALM1;DDX3X;CSF1R
240,post-Golgi vesicle-mediated transport (GO:0006892),0.6283712244774733,1.285446787519616,0.17093142272262027,0.2957120846895487,1.0,2/18,5.95%,FTH1;CLTA
242,modulation of chemical synaptic transmission (GO:0050804),0.6301581153412102,1.2828842887437761,0.17184265010351968,0.29825716761080223,1.0,2/15,2.58%,IL1B;TNF
241,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.6269291345066358,1.2834187910118715,0.17184265010351968,0.29828947297151825,1.0,8/16,22.56%,PSAP;GNAI2;RGS1;ABCA1;GNA13;RAMP1;PTGER4;GNAQ
245,regulation of protein serine/threonine kinase activity (GO:0071900),0.6139837068839022,1.2811503151077583,0.1780264496439471,0.29778679764519617,1.0,5/21,12.67%,ACTB;CDKN1A;CALM1;DDX3X;CSF1R
277,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5887794884966271,1.234823603505609,0.17853560682046138,0.3500879813440291,1.0,16/32,24.81%,ACTB;FCER1G;ARPC2;FCGR2B;ARPC1B;ARPC5;HSP90AB1;CDC42;GRB2;ACTR2;PRKCD;FGR;ACTG1;ACTR3;LYN;WIPF1
265,regulation of response to external stimulus (GO:0032101),0.6029635434048753,1.2504302926407733,0.18044354838709678,0.3328660345029954,1.0,6/26,10.62%,TREM2;TMSB4X;GRN;CALM1;FCGR2B;IRF1
230,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.6263238959519513,1.3039929581659309,0.18276220145379024,0.2724169759654916,1.0,7/16,18.23%,SDCBP;UBC;UBB;TGFBR2;HSP90AB1;DAB2;ZEB2
304,regulation of autophagy (GO:0010506),0.5505340288782276,1.1798084921115763,0.183,0.43121556875447464,1.0,6/55,4.92%,EEF1A1;TREM2;ATP6V0C;CTSA;MCL1;PSAP
333,regulation of apoptotic process (GO:0042981),0.5141156468365242,1.1230686552515103,0.183,0.5168998873353057,1.0,44/144,23.83%,CTSB;TPT1;TNF;RPS3;NFKBIA;RACK1;IGF1;AXL;GADD45B;MCL1;SQSTM1;CD74;CTSH;ANXA5;PTMA;DDX3X;PLAUR;TNFSF9;PIM1;UBC;UBB;PPT1;ARHGDIA;GNA13;PRDX5;PTPN6;SGK1;TMBIM6;NPM1;HSPA5;DAB2;YWHAZ;CALR;PHLDA1;NFKB1;CD44;HNRNPK;MIF;PMAIP1;PTK2B;FLNA;ARF4;JUN;SOD1
253,intrinsic apoptotic signaling pathway (GO:0097193),0.6072382086651337,1.2703378401560665,0.18592964824120603,0.3092630739192551,1.0,13/21,28.85%,CEBPB;CDKN1A;MCL1;DDX5;DDX3X;CRIP1;HINT1;PRKCD;PMAIP1;TNFRSF1B;BCL2L1;ATF4;PYCARD
269,external encapsulating structure organization (GO:0045229),0.5977873202127133,1.2445902059611447,0.18888888888888888,0.34048347276995505,1.0,14/22,30.65%,SPP1;ITGAX;ADAMTS1;ITGB2;SERPINE1;CD47;ITGB5;CD44;BSG;PDGFB;TGFBI;ICAM1;THBS1;APP
270,positive regulation of translation (GO:0045727),0.5956886560957446,1.2426092229226577,0.19014084507042253,0.34329827917796857,1.0,8/24,16.13%,RPS9;RPS4X;PKM;EEF2;RPL26;DDX3X;VIM;NPM1
247,neuron differentiation (GO:0030182),0.6358720238144555,1.278874174114209,0.19230769230769232,0.29969156220964904,1.0,4/15,11.40%,ID2;IER2;ITM2C;PPT1
268,interleukin-12-mediated signaling pathway (GO:0035722),0.600475447623953,1.244879114968358,0.1926977687626775,0.3412480408296607,1.0,15/22,29.09%,RPLP0;RAP1B;MSN;LCP1;CDC42;HNRNPA2B1;ANXA2;P4HB;MIF;SOD2;PITPNA;SOD1;TALDO1;ARF1;LMNB1
276,extracellular structure organization (GO:0043062),0.5920586912049577,1.2357395994946945,0.19534412955465588,0.34963292925514733,1.0,14/23,30.65%,SPP1;ITGAX;ADAMTS1;ITGB2;SERPINE1;CD47;ITGB5;CD44;BSG;PDGFB;TGFBI;ICAM1;THBS1;APP
258,negative regulation of viral process (GO:0048525),0.6216359436182615,1.2632600509113883,0.19540229885057472,0.3166880024974762,1.0,3/16,8.14%,ZFP36;TNF;IFITM3
273,positive regulation of proteasomal protein catabolic process (GO:1901800),0.5937571878662268,1.2399543749250905,0.19716885743174925,0.34496768724661764,1.0,3/23,6.77%,TREM2;RACK1;GABARAP
335,mitotic spindle organization (GO:0007052),-0.234387430902897,-1.1187772147878818,0.2,0.7425657120439387,0.7959798994974875,16/17,63.01%,SUN2;SBDS;NEK9;PLK2;MAPRE1;PAFAH1B1;LSM14A;STAG1;CLIP1;DCTN2;DYNC1H1;NUP98;DYNLL1;RHOA;DYNC1LI1;NDEL1
326,protein transport (GO:0015031),0.5261127556754198,1.132419166329778,0.2,0.5048459168405278,1.0,32/91,27.44%,APOE;ATP6V0C;CTSA;LAPTM5;CD74;VMP1;LAMP2;ARL5C;PPT1;ABCA1;CANX;ATP6AP1;TMED3;ATP6V1A;LRP1;RAMP1;NPM1;ATP6V1G1;ERP29;ABCG1;IL10RA;TMED2;RAB14;ARF4;TBC1D9;RAB20;ATP6V1F;CLTC;TCIRG1;ATP6V1C1;YWHAH;STX7
254,negative regulation of growth (GO:0045926),0.6134984549716654,1.269965944834839,0.20288362512873326,0.30876121825200636,1.0,5/17,11.40%,RACK1;BTG1;CDKN1A;DDX3X;PPT1
272,positive regulation of apoptotic signaling pathway (GO:2001235),0.6032830573337552,1.2409256356838947,0.20429009193054137,0.34422088461495326,1.0,6/18,17.88%,TNF;RPS3;RACK1;S100A9;S100A8;FIS1
283,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5749309148573647,1.2187250814878257,0.20481927710843373,0.37568820296657346,1.0,16/31,27.14%,FCER1G;B2M;CYBB;TAPBP;IFI30;CALR;ITGB5;NCF2;VAMP8;PSMB6;PSME1;PSMB1;CYBA;PSMB4;PSMA6;PSMA7
301,regulation of mRNA stability (GO:0043488),0.5497276219610584,1.186096023739955,0.20520520520520522,0.42193155755413336,1.0,21/43,27.14%,ZFP36;ZFP36L1;UBC;UBB;SLC11A1;PABPC1;MAPKAPK2;TENT5C;VIM;YBX1;NPM1;YWHAZ;PRKCD;HSPA8;PSMB6;PSME1;PSMB1;PSMB4;SERBP1;PSMA6;PSMA7
255,negative regulation of cell growth (GO:0030308),0.612214808936929,1.2696288271336946,0.20739219712525667,0.30818580862475736,1.0,5/17,11.40%,RACK1;BTG1;CDKN1A;DDX3X;PPT1
264,regulation of peptidyl-serine phosphorylation (GO:0033135),0.6018895631810935,1.2509157703254374,0.2078593588417787,0.3331126952061376,1.0,6/18,20.61%,TNF;RACK1;OSM;HSP90AB1;CD44;MIF
286,regulation of protein kinase activity (GO:0045859),0.5731390826788972,1.2124969436430204,0.2084592145015106,0.3848549044694448,1.0,10/26,23.83%,CSF1;TNF;CDKN1A;PTPRC;C5AR1;IQGAP1;FGR;GNAQ;PTK2B;SOD1
280,regulation of cell growth (GO:0001558),0.5731496744883038,1.2249204783354388,0.20883534136546184,0.36670327793880136,1.0,13/32,21.30%,RACK1;BTG1;CDKN1A;SDCBP;DDX3X;CXCL16;PPT1;S100A9;CDC42;SGK1;S100A8;BST2;APBB2
292,mitochondrial respiratory chain complex assembly (GO:0033108),-0.25706300584207165,-1.1991626935804867,0.21052631578947367,0.8470424131467678,0.6793969849246231,21/22,64.72%,NDUFS7;NDUFS6;NDUFA8;NDUFS8;NDUFB8;NDUFS2;NDUFA13;COX14;NDUFB7;COA5;NDUFV2;NDUFV3;NDUFB5;NDUFA7;NDUFB11;NDUFB10;NDUFA3;UQCRFS1;NDUFA1;NDUFA2;NDUFB9
285,endomembrane system organization (GO:0010256),0.5676735108956148,1.2143275319855127,0.21342685370741482,0.3823067372997965,1.0,7/30,14.72%,SRGN;SQSTM1;SYNGR1;VMP1;SERP1;TMED3;CDC42
260,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.630443579149627,1.2601636582292053,0.2142110762800418,0.3201001323967473,1.0,3/15,7.50%,RPS3;SQSTM1;TNFAIP3
275,regulation of cellular component movement (GO:0051270),0.6100958418850504,1.2369380402924075,0.21428571428571427,0.3484750237933345,1.0,2/15,5.75%,CD9;RPS19
294,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5695972966599219,1.196331852173159,0.21464393179538616,0.4099077436712674,1.0,5/31,8.92%,TMSB4X;ID2;NFKBIA;TNFAIP3;PIM1
296,regulation of mRNA catabolic process (GO:0061013),0.5565378972064499,1.1934688565566782,0.2172172172172172,0.4131715869138723,1.0,18/35,27.29%,ZFP36;ZFP36L1;UBC;UBB;PABPC1;MAPKAPK2;VIM;YWHAZ;PRKCD;HSPA8;PSMB6;PSME1;PSMB1;PSMB4;SERBP1;PSMA6;PSMA7;ZC3HAV1
321,regulation of intracellular signal transduction (GO:1902531),0.5323746472100555,1.1384879696577233,0.219,0.4985242498106771,1.0,8/73,4.68%,TREM2;IL1B;CLEC7A;TMSB4X;TNF;NFKBIA;IER3;SQSTM1
310,regulation of translation (GO:0006417),0.5422742880747629,1.164237733082963,0.225,0.4569300857618861,1.0,14/48,17.25%,RPS3;RACK1;BTG2;PATL2;RPS4X;EEF2;RPL26;DDX3X;EIF1;VIM;YBX1;NPM1;CALR;EIF3H
279,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.6102577658667989,1.2302350628771634,0.22901554404145077,0.35687716212598714,1.0,7/17,21.88%,CLEC7A;TNF;DDX3X;LGMN;FIS1;NLRP3;PMAIP1
295,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5719529048164383,1.1956515791618496,0.23269809428284854,0.40998568095514426,1.0,15/30,24.81%,ACTB;ARPC2;FCGR2B;ARPC1B;ARPC5;HSP90AB1;CDC42;GRB2;ACTR2;PRKCD;FGR;ACTG1;ACTR3;LYN;WIPF1
302,ribonucleoprotein complex assembly (GO:0022618),0.5571681101230459,1.184671175846674,0.23919597989949748,0.42361426118299134,1.0,9/38,14.52%,RPS5;RPS14;RPLP0;RPS15;RPSA;RPS19;HSP90AB1;RPL6;RPL3
284,cellular response to organonitrogen compound (GO:0071417),0.5906016036882148,1.215629311514502,0.24239350912778904,0.380990397511666,1.0,4/21,9.11%,ACTB;ZFP36L1;EGR1;RAP1B
281,RNA transport (GO:0050658),0.5886144897045275,1.2226500157100364,0.24299065420560748,0.3700372165913591,1.0,7/17,23.15%,ZFP36;ZFP36L1;TGFBR2;YBX1;HNRNPA2B1;SRSF5;RFTN1
278,cellular response to fibroblast growth factor stimulus (GO:0044344),0.6025880083895984,1.233898357580074,0.24405377456049637,0.35067171878461184,1.0,7/16,21.54%,ZFP36;ZFP36L1;NR4A1;GRB2;FGFR2;CD44;RAB14
305,positive regulation of protein kinase B signaling (GO:0051897),0.5524581688575517,1.1782037309519244,0.24524524524524524,0.43303683276500465,1.0,9/36,16.28%,CCL3;TNF;AXL;OSM;HSP90AB1;OSBPL8;CD86;GRB2;FGFR2
293,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5797287104854268,1.1976476151419502,0.25456389452332656,0.4085085441429397,1.0,3/21,7.50%,TMSB4X;NFKBIA;TNFAIP3
298,positive regulation of epithelial cell proliferation (GO:0050679),0.5649879019759104,1.1913164797053715,0.2558139534883721,0.4149226776634669,1.0,5/24,9.84%,GRN;IGF1;NR4A1;C5AR1;NRP1
290,regulation of type I interferon production (GO:0032479),0.5808610174453139,1.2035361691321,0.25612244897959185,0.3984608435327171,1.0,3/19,10.62%,CD14;TNFAIP3;IRF1
291,ephrin receptor signaling pathway (GO:0048013),0.5722484509304769,1.2001959874098043,0.25865580448065173,0.40424812671447913,1.0,10/23,24.71%,ACTB;ARPC2;SDCBP;ARPC1B;ARPC5;CDC42;ACTR2;ACTG1;ACTR3;LYN
282,cell junction organization (GO:0034330),0.6072335634651264,1.2214512542930027,0.25925925925925924,0.37106553623814437,1.0,7/17,23.00%,ACTB;C1QA;VMP1;CDC42;APBB2;ACTG1;FLNA
299,regulation of signal transduction by p53 class mediator (GO:1901796),0.5815150405595808,1.1912815500695084,0.2619775739041794,0.4136021432834713,1.0,7/21,18.37%,RPS15;RPL23;RPS20;SGK1;RPL37;MAPKAP1;RPL11
360,"regulation of transcription, DNA-templated (GO:0006355)",0.4871091342431047,1.0686530945848867,0.27,0.6011692122056559,1.0,46/204,21.83%,APOE;SPP1;IL1B;ID2;TNF;IGF1;JUNB;NFE2L2;BTG1;CEBPB;CDKN1A;CD74;FOS;CREG1;LITAF;NR4A1;DDX5;EGR1;ATF3;PFDN5;IRF1;TGIF1;KLF13;CCNL1;RPL6;STAT3;YBX1;MAFF;CD86;NPM1;IFRD1;CALR;SNX5;ZEB2;NFKB1;SBNO2;BRD2;HINT1;BHLHE40;PICALM;HNRNPK;ETS2;BHLHE41;APBB2;HSPA8;SOD2
288,regulation of TOR signaling (GO:0032006),0.6012504895288123,1.2049105707216334,0.27582644628099173,0.39826325096843784,1.0,1/15,0.93%,TREM2
317,regulation of protein kinase B signaling (GO:0051896),0.5348864690757773,1.1440844720306416,0.287,0.49188841160663366,1.0,10/45,16.28%,CCL3;TNF;RACK1;AXL;OSM;HSP90AB1;OSBPL8;CD86;GRB2;FGFR2
306,stress-activated MAPK cascade (GO:0051403),0.572726654289643,1.1774340441100177,0.2883435582822086,0.4334843667647108,1.0,7/21,18.62%,ZFP36;ZFP36L1;UBC;UBB;MAP3K8;PTGER4;NFKB1
308,regulation of viral genome replication (GO:0045069),0.573820942692541,1.1742619293176964,0.29162357807652534,0.43773179193260825,1.0,4/16,11.50%,TNF;DDX3X;IFITM3;PABPC1
311,positive regulation of endothelial cell migration (GO:0010595),0.5489816855413183,1.159466519661268,0.29292929292929293,0.4663577006202669,1.0,11/24,29.43%,TMSB4X;GRN;ANXA3;NRP1;LGMN;CALR;PTK2B;P2RX4;PDGFB;THBS1;RAC1
303,positive regulation of metabolic process (GO:0009893),0.5711168606347327,1.1804937943668374,0.296220633299285,0.4312761407546138,1.0,3/20,4.24%,CLEC7A;TNF;CEBPB
315,regulation of cellular response to stress (GO:0080135),0.5535051164404878,1.1494742875902921,0.2972699696663296,0.48264202977932746,1.0,7/23,16.13%,IER3;CEBPB;MCL1;ATF3;HSP90AB1;MAPKAPK2;NPM1
312,enzyme linked receptor protein signaling pathway (GO:0007167),0.5790476717353817,1.1582923948377581,0.29804727646454265,0.4674476139252891,1.0,8/17,26.75%,CSF1;AXL;CSF1R;FGFR2;FGR;PTK2B;LYN;FLT1
314,positive regulation of transferase activity (GO:0051347),0.5575878367150546,1.1502990794263461,0.30090270812437314,0.4822952954615569,1.0,8/29,16.28%,TREM2;AXL;CD74;HSP90AB1;CSF1R;HNRNPA2B1;RPS2;FGFR2
313,integrin-mediated signaling pathway (GO:0007229),0.557384008845262,1.1518123705529986,0.3035532994923858,0.48040873873191414,1.0,10/22,22.71%,PLEK;ADAMTS1;ITGB2;NRP1;CD47;CDC42;DAB2;ITGB5;FGR;PTK2B
307,positive regulation of leukocyte chemotaxis (GO:0002690),0.5730396511410676,1.1765209648882364,0.30714285714285716,0.433932205454769,1.0,6/17,20.37%,CSF1;SERPINE1;LGMN;CSF1R;CALR;PLA2G7
309,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5676111539074016,1.166138531313378,0.30929989550679204,0.4543184242781386,1.0,5/15,20.61%,TNF;OSM;HSP90AB1;CD44;MIF
352,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.23671259842519685,-1.0829622176315652,0.3333333333333333,0.6258663528180985,0.8311557788944723,20/20,76.61%,PSMC3;PSMD14;PSMA1;PSMD4;PSMA2;RBX1;PSMB2;FBXW11;PSMB3;PSMB8;FBXL3;FBXL5;PSMB9;PSMD8;PSMA7;PSMA6;PSMB4;PSMB1;PSME1;PSMB6
316,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5506668846375289,1.1476698951304134,0.3343527013251784,0.4851765141826001,1.0,4/20,8.09%,TNF;GPX1;DDX3X;PLAUR
322,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5594051416187533,1.1374612166492726,0.33539094650205764,0.4992449332014743,1.0,7/17,24.71%,TREM2;FCGR2B;RAMP1;GNB1;PTGER4;FGR;LYN
328,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.5337552426391041,1.1302835701589649,0.33668341708542715,0.506382597698065,1.0,14/28,27.14%,B2M;CYBB;TAPBP;CALR;ITGB5;NCF2;VAMP8;PSMB6;PSME1;PSMB1;CYBA;PSMB4;PSMA6;PSMA7
348,supramolecular fiber organization (GO:0097435),0.509878700762056,1.0930820144626836,0.337,0.5644669072034407,1.0,14/55,19.83%,CST3;ITM2B;B2M;ALDOA;MYO1E;UBC;UBB;HSP90AB1;VIM;CDC42;MYO5A;MYO1F;RAC2;P4HB
323,negative regulation of cell adhesion (GO:0007162),0.569626527651527,1.1363270871325881,0.3389473684210526,0.5002966149595669,1.0,4/15,11.84%,DUSP1;PTPRC;SERPINE1;ARHGDIA
331,hemopoiesis (GO:0030097),0.5474940094832764,1.1259122078910466,0.3395252837977296,0.5135453839576736,1.0,10/21,28.65%,PLEK;PTPRC;TGFBR2;CSF1R;FGFR2;ETV6;PDGFB;FLT1;RUNX1;ATF4
318,negative regulation of cellular component organization (GO:0051129),0.5714048347137981,1.1439349934267042,0.3395252837977296,0.49070073887906207,1.0,6/15,21.39%,TNF;LGALS3;DDX3X;CDC42;HSPA5;HSPA8
319,generation of neurons (GO:0048699),0.5562757272891279,1.1396452483134627,0.3411644535240041,0.4989299210039164,1.0,4/19,9.84%,IL1B;IER2;ITM2C;NRP1
346,cellular response to oxidative stress (GO:0034599),0.5278720738846112,1.1007545166350186,0.34503510531594783,0.5500776128672277,1.0,21/33,37.82%,RPS3;NFE2L2;CYBB;FOS;GPX1;PRDX1;PRDX5;NCF2;PRKCD;SOD2;JUN;SOD1;CYBA;CPEB2;ATF4;ZC3H12A;MAPK3;PRDX6;NCF4;GSR;ATP13A2
324,regulation of Ras protein signal transduction (GO:0046578),0.5453928563979697,1.1353039206719078,0.34591836734693876,0.5012711932073459,1.0,6/19,17.64%,IGF1;SQSTM1;GABARAP;ARHGDIA;GRB2;MAPKAP1
320,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5617611699703183,1.1390196247341386,0.34607438016528924,0.4988926674424802,1.0,7/17,24.71%,TREM2;CD81;RAMP1;GNB1;PTGER4;FGR;LYN
330,activation of protein kinase activity (GO:0032147),0.5472612516139022,1.126489475651144,0.3466666666666667,0.513786442119744,1.0,9/19,25.24%,IGF1;SLC11A1;TGFBR2;OSBPL8;CD86;MAPKAP1;PRKCD;PTK2B;PDGFB
345,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.24606299212598426,-1.10336472946763,0.35294117647058826,0.6636589512227017,0.8120603015075377,20/20,75.68%,NDUFS7;NDUFS6;NDUFA8;NDUFS8;NDUFB8;NDUFS2;NDUFA13;NDUFA4;NDUFB7;NDUFV2;NDUFV3;NDUFB5;NDUFA7;NDUFB11;NDUFB10;NDUFA3;NDUFA1;NDUFA2;NDUFB9;NDUFA6
327,circulatory system development (GO:0072359),0.5554614910490769,1.1309195434861417,0.35446985446985446,0.5064602201613609,1.0,6/15,25.24%,ID2;CDKN1A;TGFBR2;CRIP1;KDM6B;PDGFB
336,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.5390127719152272,1.1175782795327904,0.355464759959142,0.5256747501650059,1.0,3/21,6.77%,RACK1;LAPTM5;GABARAP
337,regulation of translational initiation (GO:0006446),0.5366286624145887,1.116453483038819,0.3628048780487805,0.5268049841954212,1.0,15/22,36.11%,CEBPB;DDX3X;EIF1;ATF3;NPM1;EIF3H;EIF4A2;EIF4B;EIF3E;EIF4G2;ATF4;CSDE1;EIF4H;CCL5;EIF5
332,intracellular pH reduction (GO:0051452),0.5559376821758656,1.1239791510275468,0.3674321503131524,0.5164920114643364,1.0,10/15,33.09%,ATP6V0C;SLC11A1;ATP6V1A;ATP6V1G1;RAB20;ATP6V1F;TCIRG1;ATP6V1C1;ATP6V0D1;ATP6V1B2
343,regulation of cell death (GO:0010941),0.5375283368142094,1.1037880137459035,0.37067209775967414,0.546404004171241,1.0,4/21,15.20%,CTSZ;LRPAP1;UBB;LRP1
347,protein localization to cell periphery (GO:1990778),0.5221468203175033,1.095623428678211,0.37538148524923703,0.5601056262404321,1.0,8/22,23.54%,TNF;ATP1B3;CD81;MYO5A;RAMP1;TMED2;FLNA;BSG
339,inorganic cation transmembrane transport (GO:0098662),0.5251727107848132,1.109215034230553,0.3773965691220989,0.5407507802188597,1.0,13/22,36.16%,ATP6V0C;ATP1B3;SLC11A1;ATP6V1A;KCNJ2;P2RX4;ATP6V1F;SLC6A6;UCP2;ATP6V0D1;ATP1A1;SLC39A1;ATP1A3
349,phosphate-containing compound metabolic process (GO:0006796),0.5161576724975449,1.087858463235997,0.3780241935483871,0.5747796487322236,1.0,7/31,16.67%,LPL;ALDOA;CALM1;PTPRC;PFKFB3;STAT3;PGK1
341,negative regulation of cell death (GO:0060548),0.5386415064277262,1.105744185618304,0.38274111675126904,0.5452608652023282,1.0,3/19,11.99%,CSF1;LRPAP1;GPNMB
340,selective autophagy (GO:0061912),0.5503826541696258,1.107794746986596,0.3842931937172775,0.5422877078244575,1.0,4/16,13.65%,SQSTM1;UBC;UBB;VIM
350,substantia nigra development (GO:0021762),0.5317592003801735,1.0867557230910558,0.38445807770961143,0.5756365967894578,1.0,5/18,17.64%,ACTB;CALM1;CDC42;HSPA5;MAPKAP1
344,regulation of Wnt signaling pathway (GO:0030111),0.522695677743905,1.1034287092977884,0.385395537525355,0.5455321207320679,1.0,4/26,7.50%,ATP6V0C;RACK1;TLR2;TNFAIP3
355,protein localization to plasma membrane (GO:0072659),0.5126618143598539,1.0771526910478548,0.3868020304568528,0.5908174750409075,1.0,8/23,23.54%,TNF;ATP1B3;CD81;MYO5A;RAMP1;TMED2;FLNA;BSG
338,positive regulation of epithelial cell migration (GO:0010634),0.5324911342458596,1.1125212552263737,0.38689866939611056,0.5343356505785716,1.0,11/21,31.87%,GRN;CTSH;ANXA3;NRP1;PFN1;CALR;PTK2B;RTN4;THBS1;RAC1;ZC3H12A
342,protein homooligomerization (GO:0051260),0.5415911047764823,1.1049015744437751,0.3877551020408163,0.5455213569468866,1.0,10/19,28.85%,B2M;ALDOA;MIF;NINJ1;KCNJ2;SOD2;ACACA;ALOX5AP;SAMHD1;PYCARD
351,interleukin-1-mediated signaling pathway (GO:0070498),0.5107579879902152,1.0844513197262386,0.3893893893893894,0.5791470499339748,1.0,14/37,27.14%,IL1B;NFKBIA;SQSTM1;EGR1;UBC;UBB;MAP3K8;NFKB1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
357,negative regulation of immune response (GO:0050777),0.5144796424535268,1.075167689473929,0.3907351460221551,0.5918364687768092,1.0,7/27,17.01%,TREM2;LGALS3;TNFAIP3;FCGR2B;RAMP1;GNB1;PTGER4
354,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5056081377973386,1.077805455144956,0.39779559118236474,0.5910048378077503,1.0,14/36,28.85%,TMSB4X;TNF;NFKBIA;TNFSF9;TNFRSF1B;PTK2B;PSMB6;PSME1;PSMB1;PSMB4;EIF5A;PSMA6;PSMA7;PYCARD
361,cellular response to metal ion (GO:0071248),0.5120942723443973,1.064923258076466,0.399592252803262,0.6079697822984174,1.0,8/21,25.73%,B2M;FOS;LGMN;CLIC4;IQGAP1;P2RX4;JUN;ALOX5AP
371,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.24594195769798327,-1.0351055953497712,0.4,0.5945977362219025,0.8663316582914573,19/19,75.68%,NDUFS7;NDUFS6;NDUFA8;NDUFS8;NDUFB8;NDUFS2;NDUFA13;NDUFB7;NDUFV2;NDUFV3;NDUFB5;NDUFA7;NDUFB11;NDUFB10;NDUFA3;NDUFA1;NDUFA2;NDUFB9;NDUFA6
372,NADH dehydrogenase complex assembly (GO:0010257),-0.24594195769798327,-1.0351055953497712,0.4,0.5945977362219025,0.8663316582914573,19/19,75.68%,NDUFS7;NDUFS6;NDUFA8;NDUFS8;NDUFB8;NDUFS2;NDUFA13;NDUFB7;NDUFV2;NDUFV3;NDUFB5;NDUFA7;NDUFB11;NDUFB10;NDUFA3;NDUFA1;NDUFA2;NDUFB9;NDUFA6
358,protein localization to membrane (GO:0072657),0.5033166937189059,1.071688560946849,0.4050251256281407,0.597753160891263,1.0,12/33,23.54%,TNF;ATP1B3;CD81;ITGB2;ARL5C;MYO5A;RAMP1;SH3GLB1;TMED2;FLNA;RFTN1;BSG
353,lymphocyte differentiation (GO:0030098),0.527015238854404,1.0784558870719017,0.41139896373056994,0.591181891442912,1.0,3/17,7.55%,AXL;TPD52;PTPRC
370,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4802049755232552,1.0356393918483835,0.412,0.6582893240832272,1.0,34/94,27.05%,CSF1;ACTB;ATP6V0C;IGF1;AXL;CYBB;ARPC2;SDCBP;ARPC1B;NRP1;ARPC5;MAPKAPK2;CSF1R;ATP6AP1;ATP6V1A;CDC42;STAT3;GRB2;FGFR2;ATP6V1G1;ACTR2;NCF2;FGR;RAB14;ACTG1;PTK2B;ACTR3;ATP6V1F;CYBA;LYN;PDGFB;TCIRG1;FLT1;ATP6V1C1
356,cellular response to peptide hormone stimulus (GO:0071375),0.5288150225283823,1.0754276460727477,0.4148827726809378,0.5929402766881727,1.0,7/19,20.03%,PKM;ZFP36L1;NR4A1;MYO5A;GOT1;NFKB1;PRKCD
359,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5105097722495122,1.0695451788451604,0.42190669371196754,0.6009018417474935,1.0,3/23,6.77%,RACK1;NFE2L2;GABARAP
362,sphingolipid metabolic process (GO:0006665),0.5003060016097408,1.0602740358889926,0.4264264264264264,0.6166137846419555,1.0,10/34,20.66%,CTSA;HEXA;PSAP;HEXB;GM2A;PPT1;SGPL1;GLTP;GLB1;ASAH1
363,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.5016795229011513,1.0602561777040416,0.4321608040201005,0.6149336227114861,1.0,4/28,8.04%,CLEC7A;TNF;GPX1;DDX3X
369,cellular component assembly (GO:0022607),0.4906102111844008,1.037969460514766,0.443,0.6546946579451096,1.0,19/42,29.68%,ACTB;CD74;VMP1;TAPBP;LCP1;CDC42;YWHAZ;CAPG;RAC2;PICALM;ACTG1;PTK2B;FLNA;WIPF1;RTN4;REPS2;STX7;RAC1;ARL6IP1
364,cellular response to chemical stress (GO:0062197),0.5073791512315389,1.0568874951724228,0.44477911646586343,0.620584523615827,1.0,17/27,37.82%,NFE2L2;CYBB;GPX1;DDX3X;PRDX1;PRDX5;NCF2;SOD2;SOD1;CYBA;CPEB2;ATF4;ZC3H12A;PRDX6;NCF4;GSR;ATP13A2
366,positive regulation of Wnt signaling pathway (GO:0030177),0.4970804211152452,1.0525698101053926,0.4493480441323972,0.6270058396235069,1.0,14/34,28.46%,ATP6V0C;TLR2;TNFAIP3;DDX3X;FGFR2;ZEB2;NFKB1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;ATP6AP2
365,small GTPase mediated signal transduction (GO:0007264),0.5160616778929867,1.0564671448512504,0.45407098121085593,0.6198273619637642,1.0,6/17,23.73%,IGF1;CDKN1A;GRB2;GNB1;RASGRP3;JUN
377,protein-containing complex assembly (GO:0065003),0.47971468802680056,1.0244769997027283,0.45845845845845845,0.6734401652880369,1.0,16/35,33.97%,CTSZ;TNF;CD74;CTSC;TAPBP;CAPG;PICALM;TMED2;PTK2B;WIPF1;REPS2;NAPA;FERMT3;ZC3H12A;RAB1A;FN1
367,response to UV (GO:0009411),0.5144685704015183,1.0420630130677138,0.46680497925311204,0.6490767360372446,1.0,7/15,28.65%,RPL26;GPX1;SDF4;NPM1;PRKCD;PCNA;ATF4
375,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.47932644546984426,1.0270154248039765,0.467,0.6713248285909418,1.0,10/73,10.62%,ID2;TNF;RPS3;RACK1;BTG2;PATL2;CDKN1A;DDX3X;PFDN5;IRF1
368,negative regulation of phosphorylation (GO:0042326),0.49915628078193225,1.03989145180973,0.4695740365111562,0.65212544516321,1.0,2/21,4.39%,SIRPA;CDKN1A
374,interferon-gamma-mediated signaling pathway (GO:0060333),0.49960592193442027,1.032753100174491,0.47438524590163933,0.6609980289475762,1.0,9/19,30.56%,B2M;IRF1;IFI30;CD44;PRKCD;TRIM25;PTAFR;ICAM1;IFNGR2
379,protein targeting (GO:0006605),0.4861523169548047,1.0217144765605763,0.4783047426841574,0.6757217730113834,1.0,8/26,20.81%,LAMP2;GABARAP;SDCBP;TSPO;ZFAND2A;FIS1;RPL11;NACA
373,heart development (GO:0007507),0.5009854639528163,1.0347632417092074,0.4815950920245399,0.6583914108225526,1.0,3/19,10.82%,ID2;CDKN1A;TGFBR2
380,response to calcium ion (GO:0051592),0.4898949588941898,1.0214130944423898,0.484504132231405,0.6746117887185836,1.0,9/18,31.38%,CALM1;LGMN;CLIC4;KCNMB3;IQGAP1;ALOX5AP;CALM2;THBS1;MEF2C
378,positive regulation of cytoskeleton organization (GO:0051495),0.5081131270314927,1.0218145741124558,0.49381443298969074,0.6773210754321657,1.0,4/17,14.72%,PLEK;NRP1;PFN1;CDC42
376,regulation of signal transduction (GO:0009966),0.4863053708509427,1.0256941366031198,0.500503524672709,0.6724806806816427,1.0,2/31,1.71%,TREM2;CD63
382,regulation of cell motility (GO:2000145),0.4957448443788269,1.0167679864443657,0.5005096839959225,0.6814971007236349,1.0,4/22,15.16%,TMSB4X;SERPINE2;CSF1R;SGK1
383,phagosome maturation (GO:0090382),0.49863229801536013,1.010496543442895,0.5015353121801432,0.6932087686918433,1.0,10/18,33.09%,ATP6V0C;ATP6V1A;ATP6V1G1;RAB14;RAB20;ATP6V1F;TCIRG1;ATP6V1C1;ATP6V0D1;ATP6V1B2
381,transferrin transport (GO:0033572),0.49694652417554364,1.018139750043316,0.5035971223021583,0.6802171403849778,1.0,10/18,33.09%,ATP6V0C;ATP6AP1;ATP6V1A;ATP6V1G1;ATP6V1F;CLTC;TCIRG1;ATP6V1C1;ATP6V0D1;ATP6V1B2
385,cellular response to amino acid starvation (GO:0034198),0.4861663158612256,1.0083219031237194,0.5045135406218656,0.6923517505152067,1.0,14/27,34.89%,ATP6V0C;CEBPB;CDKN1A;ATP6V1A;ATP6V1G1;SH3GLB1;ATP6V1F;TCIRG1;ATP6V1C1;ATF4;ATP6V0D1;MAPK3;ATP6V1B2;RRAGC
386,response to amino acid starvation (GO:1990928),0.4861663158612256,1.0083219031237194,0.5045135406218656,0.6923517505152067,1.0,14/27,34.89%,ATP6V0C;CEBPB;CDKN1A;ATP6V1A;ATP6V1G1;SH3GLB1;ATP6V1F;TCIRG1;ATP6V1C1;ATF4;ATP6V0D1;MAPK3;ATP6V1B2;RRAGC
388,membrane organization (GO:0061024),0.46689488019433517,1.0023842753998702,0.507,0.7013359754862615,1.0,23/63,26.85%,ACTB;SYNGR1;CLTA;ARPC2;UBC;UBB;ARPC5;PPT1;SERP1;GRB2;DAB2;GLTP;ACTR2;SH3GLB1;M6PR;PICALM;HSPA8;ACTG1;VAMP8;ACTR3;CLTC;REPS2;SNX3
387,regulation of organelle organization (GO:0033043),0.48092682429375566,1.0060945229812759,0.5105740181268882,0.6953606834234296,1.0,8/24,18.23%,SQSTM1;CLIC4;MSN;S100A9;MYO5A;S100A8;FIS1;ZEB2
384,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.49046733640190443,1.009251818054733,0.5168539325842697,0.6940637307904298,1.0,9/17,32.60%,ARPC2;NRP1;PFN1;CDC42;ACTR2;RAC2;ACTR3;RAC1;BRK1
391,protein deubiquitination (GO:0016579),0.4651454402649243,0.9898879108389903,0.521,0.721721337352171,1.0,14/44,27.14%,ACTB;NFKBIA;TNFAIP3;UBC;UBB;EIF3F;NLRP3;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;SNX3;PSMA7
389,protein localization to organelle (GO:0033365),0.473704578873583,0.9929935121932718,0.5260521042084169,0.7189854798875385,1.0,7/32,18.37%,CD68;LAMP2;DDX3X;SERP1;YBX1;CALR;RPL11
392,Ras protein signal transduction (GO:0007265),0.4713618780811365,0.9872872603169527,0.5297679112008072,0.7253607528907932,1.0,14/30,32.60%,IGF1;CDKN1A;RAP1B;ARHGDIA;GNA13;GRB2;GNB1;RASGRP3;RAC2;JUN;RAC1;ARHGDIB;ARHGEF1;BRK1
390,skeletal system development (GO:0001501),0.47747625149957873,0.9909467545745447,0.5301944728761515,0.7214329251861674,1.0,6/19,21.05%,IGF1;PRDX1;FGFR2;PTGER4;CD44;ETS2
396,organic substance transport (GO:0071702),0.4770157453419389,0.9780017444551636,0.532719836400818,0.7371767891092728,1.0,11/16,38.99%,GM2A;PPT1;ABCA1;RAMP1;TCN2;ABCG1;ABCD2;HSP90B1;TAP1;ARRDC4;MYH9
398,protein-containing complex subunit organization (GO:0043933),0.47828805593840323,0.9746758150072905,0.5337487019730011,0.7402845185901105,1.0,7/16,26.61%,CD74;TAPBP;CAPG;PICALM;PTK2B;WIPF1;REPS2
393,negative regulation of cell motility (GO:2000146),0.483663100563287,0.9820383100432342,0.5396498455200824,0.7347578461440101,1.0,5/16,20.76%,CD74;SERPINE1;CLIC4;MIF;BST2
395,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4565465481778138,0.9805413053212904,0.5415415415415415,0.7340114445497019,1.0,5/45,9.41%,CLEC7A;TNF;CD74;LITAF;SHISA5
397,cellular response to starvation (GO:0009267),0.46282178980370703,0.9765700185796494,0.547,0.738293985765239,1.0,19/42,33.09%,ATP6V0C;CEBPB;CDKN1A;LAMP2;GABARAP;ATP6V1A;HSPA5;ATP6V1G1;SH3GLB1;HSPA8;PMAIP1;ATP6V1F;TCIRG1;ATP6V1C1;ATF4;ATP6V0D1;ZC3H12A;MAPK3;ATP6V1B2
399,cellular response to DNA damage stimulus (GO:0006974),0.4573851342680297,0.9737447552250104,0.5480961923847696,0.7402913993984733,1.0,14/42,27.58%,RPS3;BTG2;CDKN1A;MCL1;MAPKAPK2;NPM1;GRB2;CRIP1;SUSD6;TNFRSF1B;LYN;NOP53;BCL2L1;SAMHD1
402,cellular response to transforming growth factor beta stimulus (GO:0071560),0.46157155730000465,0.9696583329126093,0.5506519558676028,0.7428194428058673,1.0,5/27,10.82%,FOS;ZFP36L1;UBC;UBB;TGFBR2
404,protein modification process (GO:0036211),0.47178508965054705,0.9683068472310025,0.5510204081632653,0.7416999973304557,1.0,4/17,17.54%,MAN2B1;SERP1;UBE2D3;RPN2
401,axonogenesis (GO:0007409),0.4638099951057988,0.9707782356981787,0.5592369477911646,0.7423941826838794,1.0,6/28,16.28%,ACTB;NRP1;HSP90AB1;NPTN;GRB2;FGFR2
405,macroautophagy (GO:0016236),0.4713862724363753,0.9663507097620295,0.5611729019211324,0.7437712862925993,1.0,3/24,6.77%,SQSTM1;LAMP2;GABARAP
394,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.46497983482757,0.9806554433301408,0.563323201621074,0.7356519512641148,1.0,7/28,18.37%,RACK1;GABARAP;SDCBP;HSP90AB1;DAB2;EIF3H;RPL11
403,negative regulation of cell migration (GO:0030336),0.46506232747823006,0.9689625394336205,0.56841046277666,0.7423270877582181,1.0,11/23,30.12%,CD74;SERPINE1;CLIC4;LRP1;CALR;ADIPOR1;MIF;BST2;TRIB1;RAC1;ARHGDIB
406,peptidyl-tyrosine phosphorylation (GO:0018108),0.4814049729253131,0.9631382067994072,0.5700836820083682,0.7483245048352238,1.0,8/15,26.75%,CSF1R;PTPN6;FGFR2;FGR;PTK2B;LYN;PDGFB;FLT1
400,protein modification by small protein removal (GO:0070646),0.4562650063351878,0.9714251600700179,0.571,0.7429824758734161,1.0,14/45,27.14%,ACTB;NFKBIA;TNFAIP3;UBC;UBB;EIF3F;NLRP3;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;SNX3;PSMA7
409,cellular response to insulin stimulus (GO:0032869),0.4591797792469633,0.9557128056612673,0.5791583166332666,0.7572479212413415,1.0,9/33,17.35%,ATP6V0C;PKM;ZFP36L1;ATP6AP1;ATP6V1A;MYO5A;GOT1;GRB2;ATP6V1G1
415,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4496276346767306,0.9361025210744585,0.5869346733668341,0.7832425315125895,1.0,5/27,10.82%,FOS;DDX5;UBC;UBB;TGFBR2
410,DNA metabolic process (GO:0006259),0.46860510674689637,0.954045249620246,0.5869786368260427,0.7585543247373427,1.0,8/21,27.58%,BTG2;UBC;UBB;NPM1;CNBP;PCNA;NOP53;SAMHD1
407,defense response to virus (GO:0051607),0.4584537216747132,0.9597253101856489,0.5877632898696088,0.7512074126339134,1.0,12/31,28.85%,TLR2;PTPRC;IFITM3;IRF1;TLR7;SERINC3;BST2;PMAIP1;FLNA;BCL2L1;SAMHD1;PYCARD
408,defense response to symbiont (GO:0140546),0.4584537216747132,0.9597253101856489,0.5877632898696088,0.7512074126339134,1.0,12/31,28.85%,TLR2;PTPRC;IFITM3;IRF1;TLR7;SERINC3;BST2;PMAIP1;FLNA;BCL2L1;SAMHD1;PYCARD
412,regulation of mitotic cell cycle (GO:0007346),0.4492361916955488,0.9471185951485136,0.5949748743718593,0.7680881750041472,1.0,11/32,27.14%,BTG2;BTG1;SDCBP;LGMN;IQGAP1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
420,cytosolic transport (GO:0016482),0.4449804380030682,0.9160590126282965,0.6,0.8099405935353323,1.0,5/17,25.05%,LAPTM5;SNX5;RAB14;SPAG9;CLTC
417,DNA repair (GO:0006281),0.45625675116383846,0.9268789723148974,0.6018329938900203,0.796297848990605,1.0,6/19,26.56%,BTG2;UBC;UBB;NPM1;PCNA;NOP53
413,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4494340118503314,0.9455683536901243,0.6028225806451613,0.7691922492011153,1.0,11/28,28.65%,NFE2L2;ATF3;UBC;UBB;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;ATF4
414,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.44312313343517556,0.9371830181103787,0.6060606060606061,0.7831616342802119,1.0,10/25,29.43%,AXL;CYBB;NRP1;MAPKAPK2;CDC42;NCF2;PTK2B;CYBA;FLT1;RAC1
418,negative regulation of protein kinase activity (GO:0006469),0.44661369928782013,0.9238697391743681,0.6069246435845214,0.7997992901873354,1.0,12/19,40.25%,CDKN1A;PTPRC;PTPN1;NPM1;GNAQ;TRIB1;PYCARD;SORL1;DUSP3;PAK2;CORO1C;RTRAF
422,regulation of myeloid cell differentiation (GO:0045637),0.4388762327147058,0.906950037523941,0.6134020618556701,0.8220935527064116,1.0,12/18,43.13%,LGALS3;PTK2B;LYN;RUNX1;THBS1;MAFB;MEF2C;PRKCB;NR4A3;SPI1;HSPA9;CDK6
416,regulation of cell adhesion (GO:0030155),0.4436446105633754,0.9277354444863246,0.6226226226226226,0.7966343754897536,1.0,12/30,30.12%,TNF;DUSP1;ARHGDIA;RAC2;P4HB;PLAU;PTK2B;LYN;TGFBI;CYTIP;CYTH1;ARHGDIB
411,negative regulation of transcription by RNA polymerase II (GO:0000122),0.43935854489862497,0.9529250617428412,0.629,0.7589520526108423,1.0,29/94,26.71%,ID2;ZFP36;RPS14;TNF;CEBPB;RPL23;SDCBP;DDX5;ATF3;UBC;UBB;TGIF1;UBE2D3;STAT3;FGFR2;DAB2;CALR;ZEB2;NFKB1;BHLHE40;ETS2;BHLHE41;CNBP;JUN;ETV6;PDGFB;NFIL3;NOP53;CUX1
424,pre-replicative complex assembly (GO:0036388),0.4371826082751042,0.9063786923803667,0.6336429308565531,0.8191101784413455,1.0,8/19,27.14%,UBC;UBB;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
426,regulation of actin cytoskeleton organization (GO:0032956),0.4447266614695668,0.9051842244150576,0.6371049949031601,0.8172568061487574,1.0,10/20,30.12%,ARHGDIA;CSF1R;LRP1;IQGAP1;RAC2;PRKCD;BST2;PTK2B;RAC1;ARHGDIB
425,insulin receptor signaling pathway (GO:0008286),0.44086733630097835,0.9053431017168475,0.6384928716904277,0.8189299691722216,1.0,14/23,40.94%,ATP6V0C;ATP6AP1;ATP6V1A;GRB2;ATP6V1G1;ATP6V1F;TCIRG1;ATP6V1C1;ATP6V0D1;ATP6V1B2;NAMPT;ATP6V0D2;IDE;AP3S1
427,B cell activation (GO:0042113),0.4431493646812754,0.9050539119200252,0.6425619834710744,0.8155279638055205,1.0,4/17,15.89%,TPD52;PTPRC;CD86;SLC25A5
431,regulation of cell cycle phase transition (GO:1901987),0.43464739191078156,0.8921489224595442,0.6444906444906445,0.8309746818442397,1.0,7/18,27.14%,CDKN1A;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
428,double-strand break repair (GO:0006302),-0.20029455081001474,-0.8944335065334288,0.6486486486486487,0.8956191970707467,0.9597989949748744,15/15,80.17%,YY1;SFR1;SMC6;DTX3L;PSMD14;KDM2A;NUCKS1;SWI5;UBXN1;DNA2;SFPQ;SUMO1;NABP1;SAMHD1;SEM1
440,phosphatidylinositol metabolic process (GO:0046488),0.43593993036435547,0.8718086621142686,0.6493775933609959,0.8456029781976591,1.0,2/15,12.67%,PLEK;CSF1R
419,positive regulation of intracellular protein transport (GO:0090316),0.43826138321920727,0.9229950828479392,0.655,0.7994567007643444,1.0,11/38,23.00%,IL1B;CD81;ITGB2;UBE2D3;YWHAZ;FIS1;RAC2;SH3GLB1;PRKCD;PMAIP1;FLNA
438,nitrogen compound transport (GO:0071705),0.41758691321398833,0.8773745970594713,0.6700404858299596,0.840918044311621,1.0,13/23,39.08%,SLC11A1;SLC15A3;PPT1;SLC3A2;RAMP1;TCN2;SLC6A6;SLC38A2;SCARB2;HSP90B1;ARRDC4;MYH9;SLC16A10
437,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.42319952047299364,0.8785395979173651,0.6725025746652935,0.8410845563878359,1.0,8/20,27.14%,UBC;UBB;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
430,cellular response to hypoxia (GO:0071456),0.4217278712345172,0.892229483372382,0.676,0.8328170732044949,1.0,15/37,28.56%,ZFP36L1;UBC;UBB;PGK1;PTGS2;P4HB;PMAIP1;PSMB6;PSME1;PSMB1;PSMB4;NOP53;PSMA6;PSMA7;CPEB2
441,transforming growth factor beta receptor signaling pathway (GO:0007179),0.41881201589542105,0.8707363435018433,0.6791120080726539,0.8452487745172637,1.0,4/24,10.82%,FOS;UBC;UBB;TGFBR2
423,negative regulation of protein phosphorylation (GO:0001933),0.4247503307315871,0.9065099453592461,0.6824120603015076,0.8208744345990544,1.0,4/35,7.55%,RACK1;SIRPA;CALM1;PTPRC
445,positive regulation of protein localization to nucleus (GO:1900182),-0.20127638684339716,-0.8630782236787614,0.6842105263157895,0.8090536593871236,0.9708542713567839,15/15,80.07%,PARK7;DTX3L;CCT8;TGFB1;CCT7;LAMTOR5;PSEN1;AKT1;CCT5;CCT4;HCLS1;CCT2;ZC3H12A;FLNA;PRKCD
433,plasma membrane bounded cell projection assembly (GO:0120031),0.4196509474782701,0.8881309450061038,0.685,0.8336098011281768,1.0,16/36,32.36%,SDCBP;FXYD5;RAP1B;NRP1;PMP22;ACTR2;EMP3;ASAP1;FLNA;ARF4;ACTR3;RILPL2;SPATA13;RAC1;ATP6V0D1;RAB1A
435,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42187650141061245,0.8852345673935389,0.6871846619576185,0.8343485464393068,1.0,9/26,27.14%,CDKN1A;ZFP36L1;GPNMB;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
429,regulation of mitotic cell cycle phase transition (GO:1901990),0.4210748391169594,0.8934355371951276,0.6880641925777332,0.8329016023424104,1.0,11/36,27.14%,ID2;ZFP36L1;UBC;UBB;PTPN6;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
444,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4278862691832064,0.863103674237609,0.6915113871635611,0.8526336484793745,1.0,2/16,9.75%,LAPTM5;UBB
447,regulation of hematopoietic stem cell differentiation (GO:1902036),0.41072375917780707,0.852200218468865,0.6917525773195876,0.8646301681382658,1.0,8/19,28.41%,OSM;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;RUNX1
434,Fc receptor signaling pathway (GO:0038093),0.4218896923260858,0.8863179080694432,0.696,0.8345426208975864,1.0,13/38,27.14%,FCER1G;CALM1;FOS;GRB2;NFKB1;PSMB6;PSME1;JUN;PSMB1;LYN;PSMB4;PSMA6;PSMA7
451,mRNA metabolic process (GO:0016071),0.40871951139474183,0.8447276773988452,0.6975806451612904,0.8673482147932562,1.0,2/21,7.65%,ZFP36;DDX5
432,Fc-epsilon receptor signaling pathway (GO:0038095),0.4214915466271337,0.8893319851813744,0.699,0.8335811558245559,1.0,17/39,33.82%,FCER1G;CALM1;FOS;GRB2;NFKB1;PSMB6;PSME1;JUN;PSMB1;LYN;PSMB4;PSMA6;PSMA7;RAC1;MAPK3;MAP3K1;NR4A3
443,positive regulation of autophagy (GO:0010508),-0.19783996072655866,-0.8688318862777481,0.7,0.869622074015954,0.9688442211055276,15/15,80.41%,TBK1;PARK7;GSK3B;ATF6;PLK2;C9ORF72;BNIP3L;GNAI3;ROCK1;PLK3;TMEM59;SCOC;MTDH;ZC3H12A;SH3GLB1
442,protein-DNA complex assembly (GO:0065004),0.4161579158683698,0.869065378386306,0.7016129032258065,0.8458294433935952,1.0,11/26,29.19%,UBC;UBB;NPM1;BRD2;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;NAP1L1
452,positive regulation of protein ubiquitination (GO:0031398),0.42187201030299915,0.8443092972270327,0.7180020811654526,0.8659079232876735,1.0,3/17,16.03%,LAPTM5;UBB;RPS2
457,positive regulation of endothelial cell proliferation (GO:0001938),0.39514029397955147,0.8108645230686071,0.7194616977225673,0.8998141474321487,1.0,2/15,9.84%,NR4A1;NRP1
448,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4058754816577854,0.8521788897049691,0.722502522704339,0.8626719571974701,1.0,9/27,27.14%,NFE2L2;UBC;UBB;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
439,regulation of nucleic acid-templated transcription (GO:1903506),0.4098381961980329,0.8755036688323998,0.7301905717151455,0.8418046400566483,1.0,18/45,31.77%,BTG1;CEBPB;PFDN5;RPL6;STAT3;YBX1;CALR;SBNO2;HINT1;BHLHE40;APBB2;CNBP;NFIL3;DENND4A;ATF4;MAFB;MEF2C;FOXN3
456,regulation of stem cell differentiation (GO:2000736),0.39201070837357715,0.8123328895723992,0.7348406988694759,0.9000089594214621,1.0,8/20,28.41%,OSM;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;RUNX1
454,central nervous system development (GO:0007417),0.39872057227832003,0.8319090048253789,0.7359437751004017,0.87885036402823,1.0,6/27,17.11%,C1QA;TGFBR2;PPT1;TPP1;STAT3;CAPG
466,positive regulation of cold-induced thermogenesis (GO:0120162),0.3886810618403772,0.7858024649473255,0.736228813559322,0.9117446109778258,1.0,5/15,28.75%,CEBPB;FABP5;ADIPOR1;KDM6B;UCP2
458,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3880547597866201,0.8079685515955831,0.7397540983606558,0.9015365264331315,1.0,10/20,36.35%,OSM;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;RUNX1;SPI1;PSMD8
449,non-canonical Wnt signaling pathway (GO:0035567),0.40360407497678535,0.8498201395754924,0.7414486921529175,0.8640859432200627,1.0,12/30,29.43%,CALM1;PFN1;CDC42;GNB1;PSMB6;PSME1;PSMB1;PSMB4;CLTC;PSMA6;PSMA7;RAC1
470,positive regulation of cell cycle (GO:0045787),0.37534423954883034,0.7741983453694155,0.7455683003128258,0.9185107630401609,1.0,7/16,34.50%,LGMN;RPS15A;FGFR2;CALR;PDGFB;APP;DUSP3
463,negative regulation of protein modification process (GO:0031400),0.3869841959051434,0.7922971079278186,0.749741468459152,0.9102767322118674,1.0,1/18,3.56%,SIRPA
460,regulation of cytoskeleton organization (GO:0051493),0.38669075682832593,0.8040969640575647,0.7619532044760936,0.9022715282841581,1.0,8/25,20.76%,CLIC4;S100A9;LRP1;IQGAP1;S100A8;RAC2;PRKCD;BST2
446,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4016223979743596,0.8623910531073324,0.7635270541082164,0.8516343145506775,1.0,22/49,35.28%,BTG1;CEBPB;PFDN5;RPL6;STAT3;YBX1;CALR;SBNO2;HINT1;BHLHE40;APBB2;CNBP;NFIL3;DENND4A;ATF4;MAFB;APP;MEF2C;FOXN3;MTPN;SPI1;NAB1
459,response to endoplasmic reticulum stress (GO:0034976),0.3823870514864349,0.8044024261046877,0.7714863498483316,0.9039216438342115,1.0,9/26,28.80%,CEBPB;ATF3;HSPA5;P4HB;OS9;JUN;HERPUD1;ATF4;THBS1
475,regulation of actin filament-based process (GO:0032970),0.3744838408859581,0.7500837663217206,0.7734864300626305,0.9334687184594744,1.0,5/15,20.76%,LRP1;IQGAP1;RAC2;PRKCD;BST2
421,cellular protein modification process (GO:0006464),0.4168368579924721,0.910740029502491,0.774,0.8174790963809359,1.0,11/182,9.41%,APOE;SPP1;CSF1;CST3;DUSP1;APLP2;MAN2B1;PTPRC;SOCS3;PIM1;SHISA5
468,regulation of anatomical structure morphogenesis (GO:0022603),0.3802801141660288,0.7790682228242916,0.778118609406953,0.9151569038362141,1.0,4/19,16.28%,TNFAIP3;GPNMB;CAPZB;FGFR2
461,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.38090850178637153,0.7993865305928468,0.779128672745694,0.9060122409389911,1.0,11/28,28.46%,DDX3X;FGFR2;ZEB2;NFKB1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;ATP6AP2
467,DNA-dependent DNA replication (GO:0006261),0.3767506034383431,0.7844144312168914,0.7805128205128206,0.9112185022225576,1.0,8/23,27.14%,UBC;UBB;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
474,type I interferon signaling pathway (GO:0060337),0.3700942638067187,0.7563052129477188,0.7855691056910569,0.929246859003562,1.0,3/19,10.62%,IFITM3;EGR1;IRF1
473,cellular response to type I interferon (GO:0071357),0.3700942638067187,0.7563052129477188,0.7855691056910569,0.929246859003562,1.0,3/19,10.62%,IFITM3;EGR1;IRF1
455,T cell receptor signaling pathway (GO:0050852),0.3865420786170124,0.8166351220134609,0.787,0.8967177261080385,1.0,12/37,27.14%,NFKBIZ;PTPRC;NFKBID;PDE4B;NFKB1;RFTN1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
482,cilium organization (GO:0044782),0.3558808969693225,0.7268060372113513,0.7917948717948718,0.9434817432941642,1.0,9/17,37.62%,ACTR2;ASAP1;FLNA;ARF4;ACTR3;RILPL2;ATP6V0D1;RAB1A;EHD4
450,intracellular protein transport (GO:0006886),0.39186606153144066,0.848639447989571,0.795,0.8638415718105732,1.0,24/71,30.46%,CTSA;LAPTM5;CD74;LAMP2;GABARAP;ARL5C;TMED3;STAT3;NPM1;CALR;ERP29;RPL11;TMED2;RAB14;ARF4;TBC1D9;RAB20;CLTC;EGR2;YWHAH;STX7;ARF1;UNC93B1;NAPA
436,"negative regulation of transcription, DNA-templated (GO:0045892)",0.4039777064453419,0.879680159455513,0.798,0.8412032582871447,1.0,35/124,26.71%,ID2;ZFP36;RPS14;TNF;CEBPB;RPL23;SDCBP;DDX5;ATF3;UBC;UBB;PFDN5;IRF1;TGIF1;UBE2D3;PRDX5;STAT3;FGFR2;DAB2;CALR;ZEB2;NFKB1;SBNO2;BHLHE40;ETS2;BHLHE41;HSPA8;CNBP;FLNA;JUN;ETV6;PDGFB;NFIL3;NOP53;CUX1
477,regulation of vesicle-mediated transport (GO:0060627),0.36318994605690097,0.7474852443590652,0.8,0.9320225954877884,1.0,5/22,21.49%,PTPRC;NRP1;PTPN1;PICALM;FGR
481,Golgi organization (GO:0007030),0.346920078974346,0.7268666504806004,0.8030456852791878,0.9454365077923459,1.0,5/20,21.10%,VMP1;TMED3;CDC42;YWHAZ;TMED2
453,cellular protein localization (GO:0034613),0.3873592831940721,0.8385307624348364,0.81,0.8718304911332337,1.0,20/63,30.46%,CD63;CTSA;LAPTM5;CD74;ARL5C;TMED3;NPM1;ERP29;TMED2;RAB14;FLNA;ARF4;TBC1D9;RAB20;CLTC;YWHAH;STX7;ARF1;UNC93B1;NAPA
462,nervous system development (GO:0007399),0.3740765049807826,0.7985501522153572,0.8108108108108109,0.9049300040178321,1.0,13/45,29.39%,ITM2B;AXL;PMP22;PPT1;TPP1;STAT3;CAPG;ZEB2;NINJ1;MBNL1;EGR2;MYLIP;MARCKS
465,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3714896059728577,0.7885480399921662,0.8166332665330661,0.9106017094378143,1.0,8/38,24.66%,CTSZ;CTSC;CAPZB;TMED3;USE1;TMED2;ARF4;ERGIC3
486,"retrograde transport, endosome to Golgi (GO:0042147)",0.34953954657305913,0.7098234245343903,0.8204857444561774,0.950216489299281,1.0,5/16,26.85%,RAB7B;SNX5;SPAG9;CLTC;SNX3
479,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.35555120017919056,0.7445358669399432,0.8240647118301314,0.9329483796354233,1.0,10/25,29.43%,PFN1;CDC42;PSMB6;PSME1;PSMB1;PSMB4;CLTC;PSMA6;PSMA7;RAC1
472,regulation of macroautophagy (GO:0016241),0.3605162461906499,0.7579613137864754,0.8242971887550201,0.9315688043788319,1.0,14/31,38.89%,ATP6V0C;ATP6V1A;ATP6V1G1;SNX5;SH3GLB1;CAPNS1;ATP6V1C1;ATP6V0D1;ATP6V1B2;RRAGC;GBA;ATP13A2;ATP6V0D2;SCOC
476,protein autophosphorylation (GO:0046777),0.36236415058375326,0.7483847552690992,0.8261306532663316,0.933160378215775,1.0,13/27,38.16%,PIM1;MAPKAPK2;CSF1R;FGFR2;FGR;PTK2B;LYN;STK17B;FLT1;MAPK3;PAK2;ATP13A2;STK10
492,regulation of cellular amino acid metabolic process (GO:0006521),0.33916431027540644,0.6962865523285056,0.8321318228630278,0.9475523658126053,1.0,9/17,40.30%,PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;OAZ1;PSMD8;PSMB9
491,regulation of cellular amine metabolic process (GO:0033238),0.33916431027540644,0.6962865523285056,0.8321318228630278,0.9475523658126053,1.0,9/17,40.30%,PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;OAZ1;PSMD8;PSMB9
493,regulation of cellular ketone metabolic process (GO:0010565),0.33916431027540644,0.6962865523285056,0.8321318228630278,0.9475523658126053,1.0,9/17,40.30%,PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;OAZ1;PSMD8;PSMB9
490,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3490108754403185,0.7016221954144162,0.8375893769152196,0.9492946971248446,1.0,6/18,27.34%,UBE2D3;YWHAZ;RAC2;SH3GLB1;PMAIP1;YWHAH
471,actin filament organization (GO:0007015),0.35743674836080036,0.7618221702602678,0.8385155466399198,0.9295538142182342,1.0,18/34,43.91%,ALDOA;MYO1E;LCP1;CDC42;MYO5A;CAPG;MYO1F;RAC2;FLNA;MARCKS;RAC1;TPM3;CORO1C;GAS2L3;RHOG;RHOA;ABI1;RHOC
503,brain development (GO:0007420),0.32460692874940705,0.6574463090190595,0.8385416666666666,0.9561870195256073,1.0,2/15,11.40%,TGFBR2;PPT1
501,mitochondrial transport (GO:0006839),0.3282267447536633,0.6677174972804915,0.8503118503118503,0.9533052303596227,1.0,6/16,32.21%,TSPO;SLC25A5;FIS1;PMAIP1;BCL2L1;TMEM14C
483,regulation of small GTPase mediated signal transduction (GO:0051056),0.3418690280992853,0.7151938966181284,0.8525252525252526,0.9518188904311168,1.0,15/28,43.91%,SQSTM1;ARHGDIA;GNA13;CDC42;RAC2;ARHGAP24;RAC1;ARHGDIB;ARHGEF1;ARHGAP45;ABR;MYO9B;RHOG;RHOA;RHOC
500,sphingolipid biosynthetic process (GO:0030148),0.3352082717954209,0.6706394058661329,0.8541448058761805,0.9531751579068216,1.0,7/15,36.84%,SGPL1;ASAH1;SGMS1;HACD2;DEGS1;ACER3;GBA
498,peptide metabolic process (GO:0006518),0.3319609818904503,0.6754497795357007,0.8581780538302277,0.9536508378317736,1.0,4/16,23.83%,GPX1;TPP1;CPD;SOD1
464,organelle assembly (GO:0070925),0.37218081102728107,0.7895526338989501,0.862,0.9113839578307492,1.0,13/55,25.15%,RPS3;PATL2;VMP1;GABARAP;DDX3X;NPM1;ACTR2;ASAP1;DDX6;FLNA;ARF4;ACTR3;RILPL2
488,dephosphorylation (GO:0016311),0.33284397550913847,0.7044463814176002,0.8624497991967871,0.950953810843764,1.0,4/29,15.94%,DUSP1;PTPRC;PTPN6;PTPN1
489,regulation of establishment of planar polarity (GO:0090175),0.33476849649444146,0.7018791071427783,0.8626262626262626,0.9510918291295414,1.0,10/26,29.43%,PFN1;CDC42;PSMB6;PSME1;PSMB1;PSMB4;CLTC;PSMA6;PSMA7;RAC1
487,cellular protein-containing complex assembly (GO:0034622),0.33694690242498704,0.7062083889118197,0.8640483383685801,0.9514342725891611,1.0,11/30,32.65%,CLTA;COX7A2L;HSP90AB1;PICALM;VAMP8;EIF4B;CYBA;CLTC;RTN4;POMP;EIF4H
485,modification-dependent protein catabolic process (GO:0019941),0.33445405798400596,0.7111602122769238,0.8698698698698699,0.9511432800585121,1.0,9/35,28.51%,SQSTM1;UBC;UBB;RNF130;RNF149;OS9;TRIM25;MYLIP;HERPUD1
499,"transcription, DNA-templated (GO:0006351)",0.325123128058056,0.6738717981053439,0.8720812182741117,0.9528717520749513,1.0,16/22,55.80%,PTMA;DDX5;KLF13;NFKB1;ATF4;RRAGC;TSC22D1;BCL3;ELOB;DRAP1;CBFB;TAF10;BTF3;CDK9;HIPK3;POLR2A
502,regulation of RNA splicing (GO:0043484),0.3133147746259772,0.6610003794680035,0.8734817813765182,0.9558067755336792,1.0,14/24,46.83%,RPS26;TMBIM6;PTBP3;HNRNPK;MBNL1;RPS13;SLC38A2;RBM39;SRSF3;CLK1;MBNL2;HNRNPH1;SF1;FUS
495,transcription by RNA polymerase II (GO:0006366),0.3222714243417013,0.6820852769463471,0.8834170854271357,0.9544373526429623,1.0,20/30,53.46%,NR4A1;DDX5;C5AR1;KLF13;NFKB1;ELL2;ATF4;SNRPB;NR4A3;RBPJ;TSC22D1;POU2F2;NOTCH2;ELOB;NABP1;DRAP1;CBFB;TAF10;BTF3;CDK9
469,nucleic acid metabolic process (GO:0090304),-0.1588785046728972,-0.7759595066411124,0.8888888888888888,0.9051111044049451,0.9879396984924623,19/19,84.31%,HNRNPA0;DDX24;HNRNPH2;WTAP;DUSP11;POLR2E;HNRNPA3;HNRNPL;HNRNPM;HNRNPU;DNA2;POLR2A;HNRNPA1;HNRNPH1;PCBP2;HNRNPC;PCBP1;HNRNPK;HNRNPA2B1
484,antigen receptor-mediated signaling pathway (GO:0050851),0.335656377276415,0.7116623535950637,0.89,0.9527410625853827,1.0,15/43,32.55%,NFKBIZ;PTPRC;NFKBID;PDE4B;NFKB1;RFTN1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;MEF2C;ZC3H12A;PRKCB
496,regulation of phosphorylation (GO:0042325),0.3268523258104121,0.6797356347536782,0.8904522613065327,0.9544331978935698,1.0,13/30,39.67%,CDKN1A;SDCBP;NRP1;MIF;LYN;PGAM1;NOP53;THBS1;APP;FN1;CCL5;CORO1C;PTGES3
497,protein dephosphorylation (GO:0006470),0.3194222828248807,0.6784097912739441,0.892678034102307,0.9535247558484502,1.0,4/31,15.94%,DUSP1;PTPRC;PTPN6;PTPN1
478,glycerophospholipid biosynthetic process (GO:0046474),-0.15108267716535434,-0.7463113556194572,0.8947368421052632,0.879822152478096,0.9909547738693467,20/20,85.09%,CSNK2A2;CDIPT;INPP4A;CLN3;MTMR3;INPP5D;CHKA;PTEN;PIK3CD;SYNJ1;MTMR6;PIK3R5;PIP5K1C;LPCAT1;SLC44A1;ARF3;ARF1;DGKD;RAB14;DGKZ
480,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3446469190346072,0.73883665673389,0.896,0.9363412531748435,1.0,21/57,36.99%,ID2;TNF;PFDN5;IRF1;CALR;SBNO2;BHLHE40;BHLHE41;HSPA8;EIF4A2;JUN;PDGFB;NFIL3;FOXN3;BCL6;RBPJ;SPI1;NAB1;PBXIP1;ENO1;JARID2
507,negative regulation of kinase activity (GO:0033673),0.3064511863937001,0.6216687794505311,0.8978102189781022,0.9705705821875242,1.0,13/15,63.69%,PTPRC;GNAQ;TRIB1;PAK2;RTRAF;CEP85;PPP2R5A;YWHAG;DTNBP1;IRS2;PPIA;HNRNPU;AKT1
510,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.28882612014110776,0.5915001200540779,0.90216271884655,0.9810626875849707,1.0,6/18,27.14%,PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
505,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.29912613995410176,0.62831410534651,0.9139676113360324,0.9705278505426298,1.0,8/23,32.36%,TAPBP;TMED3;USE1;TMED2;ARF4;ERGIC3;NAPA;RAB1A
506,axon guidance (GO:0007411),0.2979833294865779,0.6220519091033335,0.9152371342078708,0.9723048108914804,1.0,19/25,58.77%,NRP1;NPTN;GRB2;RAC2;BSG;RAC1;MAPK3;CXCR4;RHOG;GAB2;PLXNB2;ALCAM;NOTCH2;EZR;VEGFA;NRP2;KIF5B;IRS2;CYFIP1
513,regulation of RNA metabolic process (GO:0051252),0.2782511007346566,0.5683662508350664,0.9222108495394064,0.9860482475777035,1.0,12/18,52.73%,PTBP3;TNFRSF1B;MBNL1;PCBP1;CLK1;MBNL2;PCBP2;HNRNPH1;FUS;MITF;CELF1;SON
516,positive regulation of DNA biosynthetic process (GO:2000573),0.2702602305157434,0.5481628266760886,0.9246073298429319,0.9885701423748251,1.0,10/15,56.58%,HSP90AB1;PCNA;PDGFB;MAPK3;PTGES3;CCT2;HNRNPA1;KLF4;CCT4;CCT5
514,protein glycosylation (GO:0006486),0.27181955517074696,0.5643430255167399,0.9264555669050051,0.9859377613359084,1.0,7/20,35.67%,SERP1;RPN2;ST8SIA6;MAN1C1;DAD1;DDOST;B4GALT1
494,protein modification by small protein conjugation (GO:0032446),0.3238003412042356,0.6869157518457153,0.932,0.952849635101365,1.0,5/54,13.79%,RACK1;NFE2L2;UBC;UBB;UBE2D3
519,protein localization to nucleus (GO:0034504),0.26418551375154636,0.532328826118798,0.9325726141078838,0.9887737255567911,1.0,7/16,43.18%,STAT3;CALR;RPL11;NOP53;YWHAE;TOR1AIP1;BCL3
518,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2630132620502763,0.5386995163911084,0.937178166838311,0.9883370196005948,1.0,6/19,27.14%,PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
517,cell cycle G2/M phase transition (GO:0044839),0.258510278710761,0.5404520186438527,0.9373737373737374,0.9896452209899003,1.0,1/24,4.39%,CDKN1A
520,G2/M transition of mitotic cell cycle (GO:0000086),0.25176344316772614,0.5275883481704177,0.9395770392749244,0.9885812225441923,1.0,1/25,4.39%,CDKN1A
515,proteasomal protein catabolic process (GO:0010498),0.26185810415689503,0.5579414499846084,0.964964964964965,0.9866307101212626,1.0,10/42,27.14%,NFE2L2;UBE2D3;ZFAND2A;PMAIP1;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7
504,ubiquitin-dependent protein catabolic process (GO:0006511),0.3036284943531778,0.6495505085244602,0.967,0.9595116003791787,1.0,17/67,28.51%,NFE2L2;SQSTM1;TNFAIP3;UBE2D3;ZFAND2A;RNF130;RNF149;OS9;TRIM25;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;MYLIP;HERPUD1
509,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.28140993327513103,0.6032970185442814,0.974,0.9768238149882665,1.0,15/58,28.51%,NFE2L2;UBC;UBB;UBE2D3;HSPA5;ZFAND2A;OS9;TRIM25;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;HERPUD1
527,cilium assembly (GO:0060271),0.20459598899606543,0.42875105527939,0.9769769769769769,1.0,1.0,20/29,62.82%,ACTR2;ASAP1;FLNA;ARF4;ACTR3;RILPL2;ATP6V0D1;RAB1A;EHD4;YWHAE;TUBA4A;PKHD1;DYNLRB1;DYNLL1;YWHAG;EHD1;DYNC1H1;DCTN2;SNX10;CSNK1D
524,peptidyl-serine modification (GO:0018209),0.2222291752301302,0.46971521519095955,0.9779559118236473,0.9984721148143987,1.0,5/32,20.03%,TGFBR2;MAPKAPK2;SGK1;CAMK1D;PRKCD
525,peptidyl-serine phosphorylation (GO:0018105),0.21554414798860486,0.45643043025390023,0.9799599198396793,0.9998294535085755,1.0,5/33,20.03%,TGFBR2;MAPKAPK2;SGK1;CAMK1D;PRKCD
523,RNA metabolic process (GO:0016070),0.22682386891518505,0.48025262199324087,0.9818731117824774,0.9977216248781393,1.0,5/31,20.32%,DDX3X;APOBEC1;HNRNPA2B1;RBMS1;HNRNPK
522,aerobic electron transport chain (GO:0019646),0.23178780936236265,0.49130749196773416,0.9829488465396189,0.9965857976225319,1.0,26/37,62.57%,COX6A1;COX7A2L;COX8A;COX4I1;UQCRH;NDUFA6;NDUFB9;NDUFA2;UQCR11;NDUFA1;UQCRFS1;COX6B1;UQCRQ;COX5B;NDUFA3;COX6C;NDUFB10;NDUFB11;NDUFA7;NDUFB5;COX5A;NDUFV3;NDUFV2;SDHC;UQCR10;SDHA
521,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.23178780936236265,0.49130749196773416,0.9829488465396189,0.9965857976225319,1.0,26/37,62.57%,COX6A1;COX7A2L;COX8A;COX4I1;UQCRH;NDUFA6;NDUFB9;NDUFA2;UQCR11;NDUFA1;UQCRFS1;COX6B1;UQCRQ;COX5B;NDUFA3;COX6C;NDUFB10;NDUFB11;NDUFA7;NDUFB5;COX5A;NDUFV3;NDUFV2;SDHC;UQCR10;SDHA
508,protein phosphorylation (GO:0006468),0.2856043001780799,0.6138372940277331,0.985,0.9729769867530492,1.0,21/87,26.75%,TLR2;PIM1;TGFBR2;MAPKAPK2;CSF1R;TLR7;PTPN6;SGK1;FGFR2;YWHAZ;CDK8;CAMK1D;BRD2;PRKCD;FGR;PTK2B;LYN;PDGFB;STK17B;TRIB1;FLT1
512,phosphorylation (GO:0016310),0.26830035045628536,0.5776419455006057,0.986,0.9838822260684875,1.0,28/76,38.16%,PIM1;TGFBR2;MAPKAPK2;STAT3;DGKZ;SGK1;PGK1;YWHAZ;CDK8;BRD2;PRKCD;NADK;FGR;PTK2B;LYN;PDGFB;STK17B;TRIB1;DGKD;APP;PRKCB;MAPK3;MAP3K1;PRKCH;PAK2;HCST;GK;STK10
528,mitochondrion organization (GO:0007005),0.20375038165081416,0.4221585494180243,0.987891019172553,1.0,1.0,3/23,17.88%,COX7A2L;TSPO;FIS1
531,nuclear export (GO:0051168),0.1833228086646585,0.37672415251142777,0.9886010362694301,1.0,1.0,4/15,34.11%,CALR;SRSF5;EGR2;SRSF3
530,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.18405524945994473,0.3882875092667077,0.9889336016096579,1.0,1.0,18/27,64.77%,DDX5;HNRNPK;MBNL1;RBM39;PRDX6;SRSF3;MBNL2;NCL;SF1;CELF2;HNRNPA1;CELF1;SON;NUP98;CIRBP;HNRNPU;SRSF9;TRA2B
529,mitotic cell cycle phase transition (GO:0044772),0.18567336332734813,0.3954825044484498,0.9909819639278558,1.0,1.0,1/36,4.39%,CDKN1A
511,protein ubiquitination (GO:0016567),0.26845860207940636,0.5777102767136985,0.992,0.9858301181292792,1.0,15/77,27.73%,RACK1;NFE2L2;UBC;UBB;UBE2D3;OS9;TRIM25;PSMB6;PSME1;PCNA;PSMB1;PSMB4;PSMA6;PSMA7;MYLIP
533,phosphatidylinositol biosynthetic process (GO:0006661),0.164957161278921,0.33840263241669644,0.9948875255623721,1.0,1.0,1/18,8.58%,SOCS3
532,RNA processing (GO:0006396),0.17440551931259968,0.37278571227865864,0.9979939819458375,1.0,1.0,21/42,53.56%,APOBEC1;HNRNPA2B1;RBMS1;HNRNPK;SRSF5;MBNL1;SF3B1;SNRPB;RBM39;RRAGC;HNRNPC;SF3B2;RP9;HNRNPH1;ALKBH5;FUS;CELF2;LSM4;CELF1;SON;SFPQ
526,protein polyubiquitination (GO:0000209),0.2027995950195703,0.433790098177947,0.999,1.0,1.0,11/57,27.73%,TNFAIP3;UBC;UBB;UBE2D3;PSMB6;PSME1;PSMB1;PSMB4;PSMA6;PSMA7;MYLIP
535,"mRNA splicing, via spliceosome (GO:0000398)",0.1317492036613009,0.28432175471962134,1.0,1.0,1.0,7/59,21.69%,DDX5;PABPC1;YBX1;HNRNPA2B1;HNRNPK;HSPA8;SRSF5
534,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.13826611304039882,0.2981446937210728,1.0,1.0,1.0,7/57,21.69%,DDX5;PABPC1;YBX1;HNRNPA2B1;HNRNPK;HSPA8;SRSF5
536,mRNA processing (GO:0006397),0.1125098462114236,0.24246073093015724,1.0,0.9998904322824278,1.0,7/63,21.69%,DDX5;PABPC1;YBX1;HNRNPA2B1;HNRNPK;HSPA8;SRSF5
